Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(1,4)-beta-D-xylan degradation
-
-
PWY-6717
(3R)-linalool biosynthesis
-
-
PWY-7709
(3R)-N-[(2S)-1-hydroxy-6-[(3R)-3-isocyanobutanamido]hexan-2-yl]-3-isocyanobutanamide biosynthesis
-
-
PWY-8320
(3S)-linalool biosynthesis
-
-
PWY-7141
(4Z,7Z,10Z,13Z,16Z)-docosapentaenoate biosynthesis (6-desaturase)
-
-
PWY-7726
(5Z)-dodecenoate biosynthesis I
-
-
PWY0-862
(5Z)-dodecenoate biosynthesis II
-
-
PWY-7858
(8E,10E)-dodeca-8,10-dienol biosynthesis
-
-
PWY-7654
(9Z)-tricosene biosynthesis
-
-
PWY-7035
(aminomethyl)phosphonate degradation
-
-
PWY-7805
(Kdo)2-lipid A modification (H. pylori)
-
-
PWY2DNV-3
(R)- and (S)-3-hydroxybutanoate biosynthesis (engineered)
-
-
PWY-7216
(R)-camphor degradation
-
-
P601-PWY
(R)-cysteate degradation
-
-
PWY-6642
(S)-camphor degradation
-
-
PWY-6989
(S)-lactate fermentation to propanoate, acetate and hydrogen
-
-
PWY-8086
(S)-propane-1,2-diol degradation
-
-
PWY-7013
(S)-reticuline biosynthesis
-
-
(S)-reticuline biosynthesis I
-
-
PWY-3581
(S)-reticuline biosynthesis II
-
-
PWY-6133
(Z)-butanethial-S-oxide biosynthesis
-
-
PWY-6900
(Z)-phenylmethanethial S-oxide biosynthesis
-
-
PWY-6539
1,2-dichloroethane degradation
-
-
12DICHLORETHDEG-PWY
1,2-propanediol biosynthesis from lactate (engineered)
-
-
PWY-7541
1,3-propanediol biosynthesis (engineered)
-
-
PWY-7385
1,5-anhydrofructose degradation
-
-
PWY-6992
1-butanol autotrophic biosynthesis (engineered)
-
-
PWY-6886
1-methylpyrrolinium biosynthesis
-
-
PWY-5315
10-cis-heptadecenoyl-CoA degradation (yeast)
-
-
PWY-7337
10-trans-heptadecenoyl-CoA degradation (MFE-dependent, yeast)
-
-
PWY-7339
10-trans-heptadecenoyl-CoA degradation (reductase-dependent, yeast)
-
-
PWY-7338
11-oxyandrogens biosynthesis
-
-
PWY-8202
15-epi-lipoxin biosynthesis
-
-
PWY66-393
1D-myo-inositol hexakisphosphate biosynthesis I (from Ins(1,4,5)P3)
-
-
PWY-6361
1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)
-
-
PWY-6362
1D-myo-inositol hexakisphosphate biosynthesis III (Spirodela polyrrhiza)
-
-
PWY-4661
1D-myo-inositol hexakisphosphate biosynthesis IV (Dictyostelium)
-
-
PWY-6372
1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)
-
-
PWY-6554
2'-deoxymugineic acid phytosiderophore biosynthesis
-
-
PWY-5912
2,3-dihydroxybenzoate biosynthesis
-
-
PWY-5901
2-acetamido-4-amino-2,4,6-trideoxy-alpha-D-galactosyl-diphospho-ditrans,octacis-undecaprenol biosynthesis
-
-
PWY-7467
2-amino-3-carboxymuconate semialdehyde degradation to 2-hydroxypentadienoate
-
-
PWY-5654
2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA
-
-
PWY-5652
2-amino-3-hydroxycyclopent-2-enone biosynthesis
-
-
PWY-7536
2-arachidonoylglycerol biosynthesis
-
-
PWY-8052
2-carboxy-1,4-naphthoquinol biosynthesis
-
-
PWY-5837
2-deoxy-alpha-D-ribose 1-phosphate degradation
-
-
PWY-7180
2-deoxy-D-glucose 6-phosphate degradation
-
-
PWY-8121
2-deoxy-D-ribose degradation I
-
-
PWY-8060
2-deoxy-D-ribose degradation II
-
-
PWY-8058
2-methyl-branched fatty acid beta-oxidation
-
-
PWY-8181
2-methylpropene degradation
-
-
PWY-7778
2-nitrobenzoate degradation I
-
-
PWY-5647
2-nitrotoluene degradation
-
-
PWY-5641
2-oxobutanoate degradation I
-
-
PWY-5130
2-oxoglutarate decarboxylation to succinyl-CoA
-
-
PWY-5084
2-oxoisovalerate decarboxylation to isobutanoyl-CoA
-
-
PWY-5046
24-epi-campesterol, fucosterol, and clionasterol biosynthesis (diatoms)
-
-
PWY-8238
3,5-dimethoxytoluene biosynthesis
-
-
PWY-7076
3,8-divinyl-chlorophyllide a biosynthesis I (aerobic, light-dependent)
-
-
CHLOROPHYLL-SYN
3,8-divinyl-chlorophyllide a biosynthesis II (anaerobic)
-
-
PWY-5531
3,8-divinyl-chlorophyllide a biosynthesis III (aerobic, light independent)
-
-
PWY-7159
3-(4-hydroxyphenyl)pyruvate biosynthesis
-
-
PWY-5886
3-dehydroquinate biosynthesis II (archaea)
-
-
PWY-6160
3-hydroxy-4-methyl-anthranilate biosynthesis I
-
-
PWY-7717
3-hydroxy-4-methyl-anthranilate biosynthesis II
-
-
PWY-7765
3-hydroxypropanoate cycle
-
-
PWY-5743
3-hydroxypropanoate/4-hydroxybutanate cycle
-
-
PWY-5789
3-hydroxyquinaldate biosynthesis
-
-
PWY-7733
3-methyl-branched fatty acid alpha-oxidation
-
-
PWY66-387
3-methylarginine biosynthesis
-
-
PWY-6511
3-methylbutanol biosynthesis (engineered)
-
-
PWY-6871
3-phenylpropanoate degradation
-
-
P281-PWY
3-phenylpropionate degradation
-
-
3-phosphoinositide biosynthesis
-
-
PWY-6352
3-phosphoinositide degradation
-
-
PWY-6368
4,4'-diapolycopenedioate biosynthesis
-
-
PWY-6767
4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis II
-
-
PWY-7282
4-aminobutanoate degradation I
-
-
PWY-6535
4-aminobutanoate degradation II
-
-
PWY-6537
4-aminobutanoate degradation III
-
-
PWY-6536
4-aminobutanoate degradation V
-
-
PWY-5022
4-coumarate degradation (aerobic)
-
-
PWY-8002
4-coumarate degradation (anaerobic)
-
-
PWY-7046
4-ethylphenol degradation (anaerobic)
-
-
PWY-6080
4-hydroxy-2(1H)-quinolone biosynthesis
-
-
PWY-6661
4-hydroxy-2-nonenal detoxification
-
-
PWY-7112
4-hydroxy-3-prenylbenzoate biosynthesis
-
-
PWY-7303
4-hydroxybenzoate biosynthesis I (eukaryotes)
-
-
PWY-5754
4-hydroxybenzoate biosynthesis III (plants)
-
-
PWY-6435
4-nitrophenol degradation I
-
-
PWY-5487
4-nitrophenol degradation II
-
-
PWY-5488
4-oxopentanoate degradation
-
-
PWY-7948
5'-deoxyadenosine degradation I
-
-
PWY-8130
5'-deoxyadenosine degradation II
-
-
PWY-8131
5,6-dimethylbenzimidazole biosynthesis I (aerobic)
-
-
PWY-5523
5-aminoimidazole ribonucleotide biosynthesis I
-
-
PWY-6121
5-aminoimidazole ribonucleotide biosynthesis II
-
-
PWY-6122
5-nitroanthranilate degradation
-
-
PWY-7044
5-oxo-L-proline metabolism
-
-
PWY-7942
6-gingerol analog biosynthesis (engineered)
-
-
PWY-6920
6-hydroxymethyl-dihydropterin diphosphate biosynthesis
-
-
6-hydroxymethyl-dihydropterin diphosphate biosynthesis I
-
-
PWY-6147
6-hydroxymethyl-dihydropterin diphosphate biosynthesis IV (Plasmodium)
-
-
PWY-7852
7-(3-amino-3-carboxypropyl)-wyosine biosynthesis
-
-
PWY-7286
8-amino-7-oxononanoate biosynthesis I
-
-
PWY-6519
8-amino-7-oxononanoate biosynthesis IV
-
-
PWY-8203
9-cis, 11-trans-octadecadienoyl-CoA degradation (isomerase-dependent, yeast)
-
-
PWY-7340
ABH and Lewis epitopes biosynthesis from type 1 precursor disaccharide
-
-
PWY-7832
ABH and Lewis epitopes biosynthesis from type 2 precursor disaccharide
-
-
PWY-7831
abscisic acid biosynthesis
-
-
PWY-695
Ac/N-end rule pathway
-
-
PWY-7800
Acarbose and validamycin biosynthesis
-
-
acetaldehyde biosynthesis I
-
-
PWY-6333
acetaldehyde biosynthesis II
-
-
PWY-6330
acetate and ATP formation from acetyl-CoA I
-
-
PWY0-1312
acetate and ATP formation from acetyl-CoA III
-
-
PWY-8328
acetate conversion to acetyl-CoA
-
-
PWY0-1313
acetoacetate degradation (to acetyl CoA)
-
-
ACETOACETATE-DEG-PWY
acetone degradation I (to methylglyoxal)
-
-
PWY-5451
acetone degradation III (to propane-1,2-diol)
-
-
PWY-7466
acetyl CoA biosynthesis
-
-
acetyl-CoA biosynthesis from citrate
-
-
PWY-5172
acetyl-CoA fermentation to butanoate
-
-
PWY-5676
acetylene degradation (anaerobic)
-
-
P161-PWY
acridone alkaloid biosynthesis
-
-
PWY-5958
acrylate degradation I
-
-
PWY-6373
acrylonitrile degradation I
-
-
PWY-7308
acyl carrier protein activation
-
-
PWY-6012-1
acyl carrier protein metabolism
-
-
PWY-6012
acyl-CoA hydrolysis
-
-
PWY-5148
acylceramide biosynthesis and processing
-
-
PWY-8042
adenine and adenosine salvage I
-
-
P121-PWY
adenine and adenosine salvage II
-
-
PWY-6605
adenine and adenosine salvage III
-
-
PWY-6609
adenine and adenosine salvage V
-
-
PWY-6611
adenine and adenosine salvage VI
-
-
PWY-6619
adenine salvage
-
-
PWY-6610
adenosine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7227
adenosine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7220
adenosine nucleotides degradation I
-
-
PWY-6596
adenosine nucleotides degradation II
-
-
SALVADEHYPOX-PWY
adenosine ribonucleotides de novo biosynthesis
-
-
PWY-7219
adipate biosynthesis
-
-
PWY-8347
adlupulone and adhumulone biosynthesis
-
-
PWY-7857
aerobic respiration I (cytochrome c)
-
-
PWY-3781
aerobic respiration II (cytochrome c) (yeast)
-
-
PWY-7279
aerobic respiration III (alternative oxidase pathway)
-
-
PWY-4302
aerobic toluene degradation
-
-
Aflatoxin biosynthesis
-
-
alanine racemization
-
-
PWY-8072
Alanine, aspartate and glutamate metabolism
-
-
alginate biosynthesis
-
-
alginate biosynthesis I (algal)
-
-
PWY-6073
alginate biosynthesis II (bacterial)
-
-
PWY-6082
alginate degradation
-
-
PWY-6986
alkane biosynthesis II
-
-
PWY-7033
alkane oxidation
-
-
PWY-2724
all-trans-farnesol biosynthesis
-
-
PWY-6859
allantoin degradation
-
-
allantoin degradation to glyoxylate I
-
-
PWY-5694
allantoin degradation to glyoxylate III
-
-
PWY-5705
alliin metabolism
-
-
PWY-5706
allopregnanolone biosynthesis
-
-
PWY-7455
alpha-linolenate biosynthesis I (plants and red algae)
-
-
PWY-5997
alpha-linolenate metabolites biosynthesis
-
-
PWY-8398
alpha-Linolenic acid metabolism
-
-
alpha-tomatine degradation
-
-
PWY18C3-5
Amaryllidacea alkaloids biosynthesis
-
-
PWY-7826
Amino sugar and nucleotide sugar metabolism
-
-
Aminoacyl-tRNA biosynthesis
-
-
Aminobenzoate degradation
-
-
aminopropanol phosphate biosynthesis II
-
-
PWY-7378
aminopropylcadaverine biosynthesis
-
-
PWY0-1303
ammonia assimilation cycle I
-
-
PWY-6963
ammonia assimilation cycle II
-
-
PWY-6964
ammonia assimilation cycle III
-
-
AMMASSIM-PWY
ammonia oxidation I (aerobic)
-
-
AMMOXID-PWY
ammonia oxidation II (anaerobic)
-
-
P303-PWY
ammonia oxidation III
-
-
PWY-2242
anaerobic energy metabolism (invertebrates, cytosol)
-
-
PWY-7383
anaerobic energy metabolism (invertebrates, mitochondrial)
-
-
PWY-7384
anandamide biosynthesis I
-
-
PWY-8051
anandamide biosynthesis II
-
-
PWY-8053
anandamide lipoxygenation
-
-
PWY-8056
anapleurotic synthesis of oxalacetate
-
-
androgen and estrogen metabolism
-
-
androgen biosynthesis
-
-
PWY66-378
androstenedione degradation I (aerobic)
-
-
PWY-6944
androstenedione degradation II (anaerobic)
-
-
PWY-8152
ansatrienin biosynthesis
-
-
PWY-8040
anteiso-branched-chain fatty acid biosynthesis
-
-
PWY-8173
apratoxin A biosynthesis
-
-
PWY-8361
Arabinogalactan biosynthesis - Mycobacterium
-
-
arachidonate biosynthesis
-
-
arachidonate biosynthesis I (6-desaturase, lower eukaryotes)
-
-
PWY-5353
arachidonate biosynthesis IV (8-detaturase, lower eukaryotes)
-
-
PWY-7601
arachidonate biosynthesis V (8-detaturase, mammals)
-
-
PWY-7725
arachidonate metabolites biosynthesis
-
-
PWY-8397
Arachidonic acid metabolism
-
-
arachidonic acid metabolism
-
-
Arg/N-end rule pathway (eukaryotic)
-
-
PWY-7799
Arginine and proline metabolism
-
-
Arginine biosynthesis
-
-
arginine dependent acid resistance
-
-
PWY0-1299
aromatic glucosinolate activation
-
-
PWY-6684
aromatic biogenic amine degradation (bacteria)
-
-
PWY-7431
aromatic polyketides biosynthesis
-
-
PWY-6316
arsenate detoxification I
-
-
PWY-8264
arsenate detoxification II
-
-
PWY-8101
arsenate detoxification IV (mycothiol)
-
-
PWY-6421
arsenic detoxification (mammals)
-
-
PWY-4202
arsenic detoxification (plants)
-
-
PWY-8259
arsenic detoxification (yeast)
-
-
PWY-4621
arsenite to oxygen electron transfer
-
-
PWY-4521
arsenite to oxygen electron transfer (via azurin)
-
-
PWY-7429
Ascorbate and aldarate metabolism
-
-
ascorbate glutathione cycle
-
-
PWY-2261
ascorbate recycling (cytosolic)
-
-
PWY-6370
aspartate and asparagine metabolism
-
-
aspirin triggered resolvin D biosynthesis
-
-
PWY66-395
aspirin triggered resolvin E biosynthesis
-
-
PWY66-394
assimilatory sulfate reduction I
-
-
SO4ASSIM-PWY
assimilatory sulfate reduction II
-
-
SULFMETII-PWY
assimilatory sulfate reduction III
-
-
PWY-6683
assimilatory sulfate reduction IV
-
-
PWY1ZNC-1
astaxanthin biosynthesis (bacteria, fungi, algae)
-
-
PWY-5288
ATP biosynthesis
-
-
PWY-7980
atromentin biosynthesis
-
-
PWY-7518
autoinducer AI-2 biosynthesis I
-
-
PWY-6153
autoinducer AI-2 biosynthesis II (Vibrio)
-
-
PWY-6154
bacilysin biosynthesis
-
-
PWY-7626
backdoor pathway of androgen biosynthesis
-
-
PWY-8200
bacterial bioluminescence
-
-
PWY-7723
baicalein degradation (hydrogen peroxide detoxification)
-
-
PWY-7214
baicalein metabolism
-
-
PWY-7212
base-degraded thiamine salvage
-
-
PWY-6899
benzoate biosynthesis I (CoA-dependent, beta-oxidative)
-
-
PWY-6443
benzoate biosynthesis III (CoA-dependent, non-beta-oxidative)
-
-
PWY-6446
benzoyl-CoA biosynthesis
-
-
PWY-6458
benzoyl-CoA degradation I (aerobic)
-
-
PWY-1361
berberine biosynthesis
-
-
PWY-3901
beta-(1,4)-mannan degradation
-
-
PWY-7456
beta-1,4-D-mannosyl-N-acetyl-D-glucosamine degradation
-
-
PWY-7586
beta-alanine biosynthesis I
-
-
PWY-3981
beta-alanine biosynthesis II
-
-
PWY-3941
beta-Alanine metabolism
-
-
beta-carboline biosynthesis
-
-
PWY-5877
beta-D-glucuronide and D-glucuronate degradation
-
-
PWY-7247
Betalain biosynthesis
-
-
betalamic acid biosynthesis
-
-
PWY-5394
betanidin degradation
-
-
PWY-5461
betaxanthin biosynthesis
-
-
PWY-5426
betaxanthin biosynthesis (via dopamine)
-
-
PWY-5403
Bifidobacterium shunt
-
-
P124-PWY
bile acid biosynthesis, neutral pathway
bile acids deconjugation
-
-
PWY-8135
Biosynthesis of 12-, 14- and 16-membered macrolides
-
-
Biosynthesis of ansamycins
-
-
Biosynthesis of enediyne antibiotics
-
-
biosynthesis of Lewis epitopes (H. pylori)
-
-
PWY-7833
Biosynthesis of secondary metabolites
-
-
Biosynthesis of siderophore group nonribosomal peptides
-
-
Biosynthesis of unsaturated fatty acids
-
-
Biosynthesis of vancomycin group antibiotics
-
-
Biosynthesis of various secondary metabolites - part 3
-
-
biotin-carboxyl carrier protein assembly
-
-
PWY0-1264
bisabolene biosynthesis (engineered)
-
-
PWY-7102
Bisphenol degradation
-
-
bisucaberin biosynthesis
-
-
PWY-6381
botryococcenes and methylated squalene biosynthesis
-
-
PWY-6105
brassicicene C biosynthesis
-
-
PWY-7517
brassinolide biosynthesis I
-
-
PWY-699
brassinolide biosynthesis II
-
-
PWY-2582
Brassinosteroid biosynthesis
-
-
bryostatin biosynthesis
-
-
PWY-8047
bupropion degradation
-
-
PWY66-241
butachlor degradation
-
-
PWY-7771
butanoate fermentation
-
-
butanol and isobutanol biosynthesis (engineered)
-
-
PWY-7396
C20 prostanoid biosynthesis
-
-
PWY66-374
C25,25 CDP-archaeol biosynthesis
-
-
PWY-8365
C30 carotenoid biosynthesis
-
-
C4 and CAM-carbon fixation
-
-
C4 photosynthetic carbon assimilation cycle, NAD-ME type
-
-
PWY-7115
C4 photosynthetic carbon assimilation cycle, NADP-ME type
-
-
PWY-241
C4 photosynthetic carbon assimilation cycle, PEPCK type
-
-
PWY-7117
C5-Branched dibasic acid metabolism
-
-
cadaverine biosynthesis
-
-
PWY0-1601
caffeine biosynthesis I
-
-
PWY-5037
caffeine biosynthesis II (via paraxanthine)
-
-
PWY-5038
caffeine degradation III (bacteria, via demethylation)
-
-
PWY-6538
calonectrin biosynthesis
-
-
PWY-7711
Calvin-Benson-Bassham cycle
-
-
CALVIN-PWY
camalexin biosynthesis
-
-
CAMALEXIN-SYN
canavanine biosynthesis
-
-
PWY-5
canavanine degradation
-
-
PWY-31
cannabinoid biosynthesis
-
-
PWY-5140
Caprolactam degradation
-
-
capsaicin biosynthesis
-
-
PWY-5710
capsiconiate biosynthesis
-
-
PWY-6027
Carbapenem biosynthesis
-
-
Carbon fixation in photosynthetic organisms
-
-
Carbon fixation pathways in prokaryotes
-
-
carnosine biosynthesis
-
-
PWY66-420
Carotenoid biosynthesis
-
-
carotenoid biosynthesis
-
-
carotenoid cleavage
-
-
PWY-6806
catechol degradation to 2-hydroxypentadienoate I
-
-
P183-PWY
catechol degradation to 2-hydroxypentadienoate II
-
-
PWY-5419
catecholamine biosynthesis
CDP-6-deoxy-D-gulose biosynthesis
-
-
PWY-8139
CDP-diacylglycerol biosynthesis
-
-
CDP-diacylglycerol biosynthesis I
-
-
PWY-5667
CDP-diacylglycerol biosynthesis II
-
-
PWY0-1319
CDP-diacylglycerol biosynthesis III
-
-
PWY-5981
cell-surface glycoconjugate-linked phosphocholine biosynthesis
-
-
PWY-7886
cellulose and hemicellulose degradation (cellulolosome)
-
-
PWY-6784
cellulose biosynthesis
-
-
PWY-1001
cellulose degradation
-
-
cellulose degradation II (fungi)
-
-
PWY-6788
ceramide and sphingolipid recycling and degradation (yeast)
-
-
PWY-7119
ceramide biosynthesis
-
-
ceramide de novo biosynthesis
-
-
PWY3DJ-12
ceramide degradation (generic)
-
-
PWY-6483
ceramide degradation by alpha-oxidation
-
-
PWY66-388
chelerythrine biosynthesis
-
-
PWY-7507
chitin biosynthesis
-
-
PWY-6981
chitin deacetylation
-
-
PWY-7118
chitin degradation I (archaea)
-
-
PWY-6855
chitin degradation II (Vibrio)
-
-
PWY-6902
chitin degradation III (Serratia)
-
-
PWY-7822
chitin derivatives degradation
-
-
PWY-6906
Chloroalkane and chloroalkene degradation
-
-
Chlorocyclohexane and chlorobenzene degradation
-
-
chlorogenic acid degradation
-
-
PWY-6781
chlorpyrifos degradation
-
-
PWY-8065
cholesterol biosynthesis
-
-
cholesterol biosynthesis (algae, late side-chain reductase)
-
-
PWY-8191
cholesterol biosynthesis (diatoms)
-
-
PWY-8239
cholesterol biosynthesis (plants, early side-chain reductase)
-
-
PWY18C3-1
cholesterol biosynthesis I
-
-
PWY66-341
cholesterol biosynthesis II (via 24,25-dihydrolanosterol)
-
-
PWY66-3
cholesterol biosynthesis III (via desmosterol)
-
-
PWY66-4
cholesterol degradation to androstenedione I (cholesterol oxidase)
-
-
PWY-6945
cholesterol degradation to androstenedione II (cholesterol dehydrogenase)
-
-
PWY-6946
cholesterol degradation to androstenedione III (anaerobic)
-
-
PWY-8151
choline biosynthesis I
-
-
PWY-3385
choline biosynthesis III
-
-
PWY-3561
chondroitin biosynthesis
-
-
PWY-6566
chondroitin sulfate biosynthesis
-
-
PWY-6567
chondroitin sulfate degradation I (bacterial)
-
-
PWY-6572
chorismate biosynthesis from 3-dehydroquinate
-
-
PWY-6163
chorismate metabolism
-
-
cis-geranyl-CoA degradation
-
-
PWY-6672
cis-vaccenate biosynthesis
cis-zeatin biosynthesis
-
-
PWY-2781
Citrate cycle (TCA cycle)
-
-
CMP phosphorylation
-
-
PWY-7205
CMP-2-keto-3-deoxy-D-glycero-D-galacto-nononate biosynthesis
-
-
PWY-6140
CMP-diacetamido-8-epilegionaminic acid biosynthesis
-
-
PWY-7719
CMP-legionaminate biosynthesis I
-
-
PWY-6749
CMP-N-acetylneuraminate biosynthesis II (bacteria)
-
-
PWY-6139
CMP-N-glycoloylneuraminate biosynthesis
-
-
PWY-6144
CMP-pseudaminate biosynthesis
-
-
PWY-6143
CO2 fixation in Crenarchaeota
-
-
CO2 fixation into oxaloacetate (anaplerotic)
-
-
PWYQT-4429
coenzyme A biosynthesis I (bacteria)
-
-
COA-PWY
coenzyme A biosynthesis III (archaea)
-
-
PWY-8342
coenzyme A metabolism
-
-
coenzyme B biosynthesis
-
-
P241-PWY
coenzyme M biosynthesis
-
-
coenzyme M biosynthesis II
-
-
PWY-6643
colanic acid building blocks biosynthesis
-
-
COLANSYN-PWY
colupulone and cohumulone biosynthesis
-
-
PWY-5133
complex N-linked glycan biosynthesis (plants)
-
-
PWY-7920
complex N-linked glycan biosynthesis (vertebrates)
-
-
PWY-7426
conversion of succinate to propanoate
-
-
PWY0-43
coumarin biosynthesis (via 2-coumarate)
-
-
PWY-5176
creatine biosynthesis
-
-
GLYCGREAT-PWY
creatine phosphate biosynthesis
-
-
PWY-6158
creatinine degradation
-
-
creatinine degradation I
-
-
CRNFORCAT-PWY
creatinine degradation II
-
-
PWY-4722
cremeomycin biosynthesis
-
-
PWY-8296
crepenynate biosynthesis
-
-
PWY-6013
crotonate fermentation (to acetate and cyclohexane carboxylate)
-
-
PWY-7401
crotonyl-CoA/ethylmalonyl-CoA/hydroxybutyryl-CoA cycle (engineered)
-
-
PWY-7854
curacin A biosynthesis
-
-
PWY-8358
cutin biosynthesis
-
-
PWY-321
Cutin, suberine and wax biosynthesis
-
-
cyanide degradation
-
-
P401-PWY
cyanide detoxification I
-
-
ASPSYNII-PWY
cyanide detoxification II
-
-
PWY-7142
Cyanoamino acid metabolism
-
-
cyclic electron flow
-
-
PWY-8270
cylindrospermopsin biosynthesis
-
-
PWY-8045
Cysteine and methionine metabolism
-
-
cytochrome c biogenesis (system I type)
-
-
PWY-8147
cytochrome c biogenesis (system II type)
-
-
PWY-8146
cytochrome c biogenesis (system III type)
-
-
PWY-8145
cytosolic NADPH production (yeast)
-
-
PWY-7268
D-Amino acid metabolism
-
-
D-arabinose degradation V
-
-
PWY-8334
D-cycloserine biosynthesis
-
-
PWY-7274
D-galactose degradation I (Leloir pathway)
-
-
PWY-6317
D-galactose degradation IV
-
-
PWY-6693
D-galactose detoxification
-
-
PWY-3821
D-glucuronate degradation I
-
-
PWY-5525
d-mannose degradation
-
-
D-myo-inositol (1,3,4)-trisphosphate biosynthesis
-
-
PWY-6364
D-myo-inositol (1,4,5)-trisphosphate biosynthesis
-
-
PWY-6351
D-myo-inositol (1,4,5)-trisphosphate degradation
-
-
PWY-6363
D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis
-
-
PWY-6366
D-myo-inositol-5-phosphate metabolism
-
-
PWY-6367
D-sorbitol biosynthesis I
-
-
PWY-5054
D-sorbitol degradation I
-
-
PWY-4101
D-xylose degradation I
-
-
XYLCAT-PWY
D-xylose degradation IV
-
-
PWY-7294
D-xylose degradation to ethylene glycol (engineered)
-
-
PWY-7178
degradation of aromatic, nitrogen containing compounds
-
-
degradation of hexoses
-
-
degradation of pentoses
-
-
degradation of sugar acids
-
-
degradation of sugar alcohols
-
-
dermatan sulfate degradation I (bacterial)
-
-
PWY-7646
desferrioxamine B biosynthesis
-
-
PWY-6376
desferrioxamine E biosynthesis
-
-
PWY-6375
detoxification of reactive carbonyls in chloroplasts
-
-
PWY-6786
di-homo-gamma-linolenate metabolites biosynthesis
-
-
PWY-8396
di-myo-inositol phosphate biosynthesis
-
-
PWY-6664
diacylglycerol and triacylglycerol biosynthesis
-
-
TRIGLSYN-PWY
diacylglycerol biosynthesis (PUFA enrichment in oilseed)
-
-
PWY-6804
diethylphosphate degradation
-
-
PWY-5491
digitoxigenin biosynthesis
-
-
PWY-6032
dimethyl sulfide biosynthesis from methionine
-
-
PWY-7793
dimethyl sulfide degradation I
-
-
PWY-6047
dimethylsulfoniopropanoate degradation I (cleavage)
-
-
PWY-6046
dimorphecolate biosynthesis
-
-
PWY-5368
dipicolinate biosynthesis
-
-
PWY-8088
dissimilatory sulfate reduction I (to hydrogen sufide))
-
-
DISSULFRED-PWY
Diterpenoid biosynthesis
-
-
divinyl ether biosynthesis II
-
-
PWY-5409
docosahexaenoate biosynthesis I (lower eukaryotes)
-
-
PWY-7053
docosahexaenoate biosynthesis III (6-desaturase, mammals)
-
-
PWY-7606
docosahexaenoate metabolites biosynthesis
-
-
PWY-8400
dolichol and dolichyl phosphate biosynthesis
dolichyl-diphosphooligosaccharide biosynthesis
-
-
dopamine degradation
-
-
PWY6666-2
drosopterin and aurodrosopterin biosynthesis
-
-
PWY-7442
Drug metabolism - cytochrome P450
-
-
Drug metabolism - other enzymes
-
-
dTDP-3-acetamido-3,6-dideoxy-alpha-D-glucose biosynthesis
-
-
PWY-7318
dTDP-3-acetamido-alpha-D-fucose biosynthesis
-
-
PWY-6953
dTDP-4-O-demethyl-beta-L-noviose biosynthesis
-
-
PWY-7301
dTDP-6-deoxy-alpha-D-allose biosynthesis
-
-
PWY-7413
dTDP-alpha-D-forosamine biosynthesis
-
-
PWY-6808
dTDP-alpha-D-mycaminose biosynthesis
-
-
PWY-7414
dTDP-alpha-D-olivose, dTDP-alpha-D-oliose and dTDP-alpha-D-mycarose biosynthesis
-
-
PWY-6973
dTDP-alpha-D-ravidosamine and dTDP-4-acetyl-alpha-D-ravidosamine biosynthesis
-
-
PWY-7688
dTDP-beta-D-fucofuranose biosynthesis
-
-
PWY-7312
dTDP-beta-L-4-epi-vancosamine biosynthesis
-
-
PWY-7440
dTDP-beta-L-digitoxose biosynthesis
-
-
PWY-7657
dTDP-beta-L-megosamine biosynthesis
-
-
PWY-7104
dTDP-beta-L-mycarose biosynthesis
-
-
PWY-6976
dTDP-beta-L-olivose biosynthesis
-
-
PWY-6974
dTDP-beta-L-rhamnose biosynthesis
-
-
DTDPRHAMSYN-PWY
dTDP-D-desosamine biosynthesis
-
-
PWY-6942
dTDP-L-daunosamine biosynthesis
-
-
PWY-7814
dTDP-N-acetylthomosamine biosynthesis
-
-
PWY-7315
dTDP-N-acetylviosamine biosynthesis
-
-
PWY-7316
dTDP-sibirosamine biosynthesis
-
-
PWY-8380
dTDPLrhamnose biosynthesis
-
-
dTMP de novo biosynthesis (mitochondrial)
-
-
PWY66-385
dZTP biosynthesis
-
-
PWY-8289
echinatin biosynthesis
-
-
PWY-6325
ectoine biosynthesis
-
-
P101-PWY
ent-kaurene biosynthesis I
-
-
PWY-5032
enterobactin biosynthesis
Entner Doudoroff pathway
-
-
Entner-Doudoroff pathway I
-
-
PWY-8004
Entner-Doudoroff pathway II (non-phosphorylative)
-
-
NPGLUCAT-PWY
Entner-Doudoroff pathway III (semi-phosphorylative)
-
-
PWY-2221
epoxysqualene biosynthesis
-
-
PWY-5670
ergosterol biosynthesis I
-
-
PWY-6075
ergosterol biosynthesis II
-
-
PWY-7154
ergothioneine biosynthesis I (bacteria)
-
-
PWY-7255
erythritol biosynthesis I
-
-
PWY-8372
erythritol biosynthesis II
-
-
PWY-8373
erythro-tetrahydrobiopterin biosynthesis I
-
-
PWY-5663
erythromycin D biosynthesis
-
-
PWY-7106
Escherichia coli serotype O:127 O antigen biosynthesis
-
-
PWY-8231
Escherichia coli serotype O:1B/Salmonella enterica serotype O:42 O antigen biosynthesis
-
-
PWY-8237
Escherichia coli serotype O:85/Salmonella enterica serotype O:17 O antigen biosynthesis
-
-
PWY-8207
Escherichia coli serotype O:86 O antigen biosynthesis
-
-
PWY-7290
Escherichia coli serotype O:9 O antigen biosynthesis
-
-
PWY-8250
Escherichia coli serotype O:9a O antigen biosynthesis
-
-
PWY-7905
estradiol biosynthesis I (via estrone)
-
-
PWY66-380
ethanol degradation I
-
-
ETOH-ACETYLCOA-ANA-PWY
ethanol degradation II
-
-
PWY66-21
ethanol degradation III
-
-
PWY66-161
ethanol degradation IV
-
-
PWY66-162
ethanolamine utilization
-
-
PWY0-1477
ethene biosynthesis I (plants)
-
-
ETHYL-PWY
ethene biosynthesis II (microbes)
-
-
PWY-6853
ethene biosynthesis III (microbes)
-
-
PWY-6854
ethene biosynthesis IV (engineered)
-
-
PWY-7126
ethene biosynthesis V (engineered)
-
-
PWY-7124
Ether lipid metabolism
-
-
ethiin metabolism
-
-
PWY-5708
Ethylbenzene degradation
-
-
ethylbenzene degradation (anaerobic)
-
-
PWY-481
ethylmalonyl-CoA pathway
-
-
PWY-5741
eumelanin biosynthesis
-
-
PWY-6498
even iso-branched-chain fatty acid biosynthesis
-
-
PWY-8175
farnesylcysteine salvage pathway
-
-
PWY-6577
fatty acid alpha-oxidation I (plants)
-
-
PWY-2501
fatty acid beta-oxidation I (generic)
-
-
FAO-PWY
fatty acid beta-oxidation II (plant peroxisome)
-
-
PWY-5136
fatty acid beta-oxidation IV (unsaturated, even number)
-
-
PWY-5138
fatty acid beta-oxidation V (unsaturated, odd number, di-isomerase-dependent)
-
-
PWY-6837
fatty acid beta-oxidation VI (mammalian peroxisome)
-
-
PWY66-391
fatty acid beta-oxidation VII (yeast peroxisome)
-
-
PWY-7288
Fatty acid biosynthesis
-
-
fatty acid biosynthesis initiation (mitochondria)
-
-
PWY66-429
fatty acid biosynthesis initiation (plant mitochondria)
-
-
PWY-6799
fatty acid biosynthesis initiation (type I)
-
-
PWY-5966-1
fatty acid biosynthesis initiation (type II)
-
-
PWY-4381
Fatty acid degradation
-
-
Fatty acid elongation
-
-
fatty acid elongation -- saturated
-
-
FASYN-ELONG-PWY
fatty acid salvage
-
-
PWY-7094
Fe(II) oxidation
-
-
PWY-6692
FeMo cofactor biosynthesis
-
-
PWY-7710
ferrichrome A biosynthesis
-
-
PWY-7571
firefly bioluminescence
-
-
PWY-7913
flavin biosynthesis I (bacteria and plants)
-
-
RIBOSYN2-PWY
flavin biosynthesis II (archaea)
-
-
PWY-6167
flavin biosynthesis III (fungi)
-
-
PWY-6168
flavin salvage
-
-
PWY66-366
Flavone and flavonol biosynthesis
-
-
flavonoid biosynthesis
-
-
PWY1F-FLAVSYN
Flavonoid biosynthesis
-
-
flavonoid biosynthesis (in equisetum)
-
-
PWY-6787
flavonoid di-C-glucosylation
-
-
PWY-7897
flexixanthin biosynthesis
-
-
PWY-7947
fluoroacetate and fluorothreonine biosynthesis
-
-
PWY-6644
fluoroacetate degradation
-
-
PWY-6646
folate transformations I
-
-
PWY-2201
folate transformations II (plants)
-
-
PWY-3841
folate transformations III (E. coli)
-
-
1CMET2-PWY
formaldehyde assimilation I (serine pathway)
-
-
PWY-1622
formaldehyde assimilation II (assimilatory RuMP Cycle)
-
-
PWY-1861
formaldehyde assimilation III (dihydroxyacetone cycle)
-
-
P185-PWY
formaldehyde oxidation
-
-
formaldehyde oxidation I
-
-
RUMP-PWY
formaldehyde oxidation II (glutathione-dependent)
-
-
PWY-1801
formaldehyde oxidation VII (THF pathway)
-
-
PWY-7909
formate assimilation into 5,10-methylenetetrahydrofolate
-
-
PWY-1722
formate oxidation to CO2
-
-
PWY-1881
formate to dimethyl sulfoxide electron transfer
-
-
PWY0-1356
formate to nitrite electron transfer
-
-
PWY0-1585
fructan degradation
-
-
PWY-862
fructose 2,6-bisphosphate biosynthesis
-
-
PWY66-423
Fructose and mannose metabolism
-
-
fusicoccin A biosynthesis
-
-
PWY-6659
GABA shunt I
-
-
GLUDEG-I-PWY
GABA shunt II
-
-
PWY-8346
gala-series glycosphingolipids biosynthesis
-
-
PWY-7840
gallate degradation III (anaerobic)
-
-
P3-PWY
gamma-glutamyl cycle
-
-
PWY-4041
gamma-linolenate biosynthesis II (animals)
-
-
PWY-6000
ganglio-series glycosphingolipids biosynthesis
-
-
PWY-7836
GDP-6-deoxy-D-talose biosynthesis
-
-
PWY-5738
GDP-alpha-D-glucose biosynthesis
-
-
PWY-5661
GDP-D-perosamine biosynthesis
-
-
PWY-5739
GDP-D-rhamnose biosynthesis
-
-
GDPRHAMSYN-PWY
GDP-L-colitose biosynthesis
-
-
PWY-5740
GDP-L-fucose biosynthesis I (from GDP-D-mannose)
-
-
PWY-66
GDP-mannose biosynthesis
-
-
PWY-5659
GDP-mycosamine biosynthesis
-
-
PWY-7573
GDP-N-acetyl-alpha-D-perosamine biosynthesis
-
-
PWY-8225
GDP-N-formyl-alpha-D-perosamine biosynthesis
-
-
PWY2B4Q-2
gentisate degradation I
-
-
PWY-6223
geranyl diphosphate biosynthesis
-
-
PWY-5122
geranylgeranyl diphosphate biosynthesis
-
-
PWY-5120
gibberellin inactivation I (2beta-hydroxylation)
-
-
PWY-102
ginkgotoxin biosynthesis
-
-
PWY-8077
ginsenoside metabolism
-
-
ginsenosides biosynthesis
-
-
PWY-5672
gliotoxin biosynthesis
-
-
PWY-7533
globo-series glycosphingolipids biosynthesis
-
-
PWY-7838
glucocorticoid biosynthesis
-
-
PWY66-381
gluconeogenesis I
-
-
GLUCONEO-PWY
gluconeogenesis II (Methanobacterium thermoautotrophicum)
-
-
PWY-6142
gluconeogenesis III
-
-
PWY66-399
glucose and glucose-1-phosphate degradation
-
-
GLUCOSE1PMETAB-PWY
glucose degradation (oxidative)
-
-
DHGLUCONATE-PYR-CAT-PWY
glucosinolate activation
-
-
PWY-5267
Glucosinolate biosynthesis
-
-
glucosinolate biosynthesis from dihomomethionine
-
-
PWYQT-4471
glucosinolate biosynthesis from hexahomomethionine
-
-
PWYQT-4475
glucosinolate biosynthesis from homomethionine
-
-
PWY-1187
glucosinolate biosynthesis from pentahomomethionine
-
-
PWYQT-4474
glucosinolate biosynthesis from phenylalanine
-
-
PWY-2821
glucosinolate biosynthesis from tetrahomomethionine
-
-
PWYQT-4473
glucosinolate biosynthesis from trihomomethionine
-
-
PWYQT-4472
glucosinolate biosynthesis from tryptophan
-
-
PWY-601
glucosinolate biosynthesis from tyrosine
-
-
PWY-7901
glucosylglycerol biosynthesis
-
-
PWY-7902
glutamate and glutamine metabolism
-
-
glutamate removal from folates
-
-
PWY-2161B
glutaminyl-tRNAgln biosynthesis via transamidation
-
-
PWY-5921
glutaryl-CoA degradation
-
-
PWY-5177
glutathione biosynthesis
-
-
GLUTATHIONESYN-PWY
glutathione degradation (DUG pathway)
-
-
PWY-7559
Glutathione metabolism
-
-
glutathione metabolism
-
-
glutathione-mediated detoxification I
-
-
PWY-4061
glutathione-mediated detoxification II
-
-
PWY-6842
glutathione-peroxide redox reactions
-
-
PWY-4081
glycerol degradation I
-
-
PWY-4261
glycerol degradation II
-
-
PWY-6131
glycerol degradation to butanol
-
-
PWY-7003
glycerol degradation V
-
-
GLYCEROLMETAB-PWY
glycerol-3-phosphate shuttle
-
-
PWY-6118
glycerol-3-phosphate to cytochrome bo oxidase electron transfer
-
-
PWY0-1561
glycerol-3-phosphate to fumarate electron transfer
-
-
PWY0-1582
glycerol-3-phosphate to hydrogen peroxide electron transport
-
-
PWY0-1591
Glycerolipid metabolism
-
-
glycerophosphodiester degradation
-
-
PWY-6952
Glycerophospholipid metabolism
-
-
glycine betaine biosynthesis
-
-
glycine betaine biosynthesis IV (from glycine)
-
-
P541-PWY
glycine betaine biosynthesis V (from glycine)
-
-
PWY-6004
glycine betaine degradation I
-
-
PWY-3661
glycine betaine degradation II (mammalian)
-
-
PWY-3661-1
glycine betaine degradation III
-
-
PWY-8325
glycine biosynthesis I
-
-
GLYSYN-PWY
glycine biosynthesis II
-
-
GLYCINE-SYN2-PWY
glycine biosynthesis III
-
-
GLYSYN-ALA-PWY
glycine biosynthesis IV
-
-
GLYSYN-THR-PWY
glycine cleavage
-
-
GLYCLEAV-PWY
glycine degradation (reductive Stickland reaction)
-
-
PWY-8015
Glycine, serine and threonine metabolism
-
-
glycogen biosynthesis
-
-
glycogen biosynthesis I (from ADP-D-Glucose)
-
-
GLYCOGENSYNTH-PWY
glycogen biosynthesis II (from UDP-D-Glucose)
-
-
PWY-5067
glycogen biosynthesis III (from alpha-maltose 1-phosphate)
-
-
PWY-7900
glycogen degradation I
-
-
GLYCOCAT-PWY
glycogen degradation II
-
-
PWY-5941
glycolate and glyoxylate degradation II
-
-
GLYOXDEG-PWY
Glycolysis / Gluconeogenesis
-
-
glycolysis I (from glucose 6-phosphate)
-
-
GLYCOLYSIS
glycolysis II (from fructose 6-phosphate)
-
-
PWY-5484
glycolysis III (from glucose)
-
-
ANAGLYCOLYSIS-PWY
glycolysis IV
-
-
PWY-1042
glycolysis V (Pyrococcus)
-
-
P341-PWY
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate
-
-
Glycosaminoglycan biosynthesis - heparan sulfate / heparin
-
-
Glycosaminoglycan biosynthesis - keratan sulfate
-
-
Glycosaminoglycan degradation
-
-
glycosaminoglycan-protein linkage region biosynthesis
-
-
PWY-6557
Glycosphingolipid biosynthesis - ganglio series
-
-
Glycosphingolipid biosynthesis - globo and isoglobo series
-
-
Glycosphingolipid biosynthesis - lacto and neolacto series
-
-
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis
-
-
Glyoxylate and dicarboxylate metabolism
-
-
glyoxylate assimilation
-
-
PWY-5744
glyoxylate cycle
-
-
GLYOXYLATE-BYPASS
glyphosate degradation III
-
-
PWY-7807
gondoate biosynthesis (anaerobic)
-
-
PWY-7663
gossypol biosynthesis
-
-
PWY-5773
grixazone biosynthesis
-
-
PWY-7153
guadinomine B biosynthesis
-
-
PWY-7693
guaiacol biosynthesis
-
-
PWY18C3-23
guanine and guanosine salvage I
-
-
PWY-6620
guanine and guanosine salvage II
-
-
PWY-6599
guanosine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7226
guanosine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7222
guanosine nucleotides degradation I
-
-
PWY-6607
guanosine nucleotides degradation II
-
-
PWY-6606
guanosine nucleotides degradation III
-
-
PWY-6608
guanosine ribonucleotides de novo biosynthesis
-
-
PWY-7221
H. pylori 26695 O-antigen biosynthesis
-
-
PWY2DNV-5
heme b biosynthesis I (aerobic)
-
-
HEME-BIOSYNTHESIS-II
heme b biosynthesis II (oxygen-independent)
-
-
HEMESYN2-PWY
heme b biosynthesis IV (Gram-positive bacteria)
-
-
PWY-7766
heme b biosynthesis V (aerobic)
-
-
HEME-BIOSYNTHESIS-II-1
heme degradation I
-
-
PWY-5874
heparan sulfate biosynthesis
-
-
PWY-6558
heparan sulfate degradation
-
-
PWY-7651
heparin degradation
-
-
PWY-7644
heterolactic fermentation
-
-
P122-PWY
histamine biosynthesis
-
-
PWY-6173
histamine degradation
-
-
PWY-6181
homocarnosine biosynthesis
-
-
PWY66-421
homocysteine and cysteine interconversion
-
-
PWY-801
homoglutathione biosynthesis
-
-
PWY-6840
homospermidine biosynthesis I
-
-
PWY-5907
homospermidine biosynthesis II
-
-
PWY-8149
hopanoid biosynthesis (bacteria)
-
-
PWY-7072
hyaluronan degradation
-
-
PWY-7645
hydrogen sulfide biosynthesis II (mammalian)
-
-
PWY66-426
hydrogen to dimethyl sulfoxide electron transfer
-
-
PWY0-1577
hydrogen to fumarate electron transfer
-
-
PWY0-1576
hydroxycinnamic acid serotonin amides biosynthesis
-
-
PWY-5473
hydroxycinnamic acid tyramine amides biosynthesis
-
-
PWY-5474
hydroxylated fatty acid biosynthesis (plants)
-
-
PWY-6433
hypoglycin biosynthesis
-
-
PWY-5826
hypotaurine degradation
-
-
PWY-7387
i antigen and I antigen biosynthesis
-
-
PWY-7837
icosapentaenoate biosynthesis I (lower eukaryotes)
-
-
PWY-6958
icosapentaenoate biosynthesis II (6-desaturase, mammals)
-
-
PWY-7049
icosapentaenoate biosynthesis III (8-desaturase, mammals)
-
-
PWY-7724
icosapentaenoate biosynthesis V (8-desaturase, lower eukaryotes)
-
-
PWY-7602
icosapentaenoate biosynthesis VI (fungi)
-
-
PWY-6940
icosapentaenoate metabolites biosynthesis
-
-
PWY-8399
incomplete reductive TCA cycle
-
-
P42-PWY
indole glucosinolate activation (herbivore attack)
-
-
PWYQT-4476
indole glucosinolate activation (intact plant cell)
-
-
PWYQT-4477
indole-3-acetate biosynthesis II
-
-
PWY-581
indole-3-acetate biosynthesis III (bacteria)
-
-
PWY-3161
indole-3-acetate biosynthesis IV (bacteria)
-
-
PWY-5025
indole-3-acetate biosynthesis VI (bacteria)
-
-
TRPIAACAT-PWY
inosine 5'-phosphate degradation
-
-
PWY-5695
inosine-5'-phosphate biosynthesis I
-
-
PWY-6123
inosine-5'-phosphate biosynthesis II
-
-
PWY-6124
inosine-5'-phosphate biosynthesis III
-
-
PWY-7234
inositol diphosphates biosynthesis
-
-
PWY-6369
Inositol phosphate metabolism
-
-
Insect hormone biosynthesis
-
-
inulin degradation
-
-
PWY-8314
ipsdienol biosynthesis
-
-
PWY-7410
isoflavonoid biosynthesis I
-
-
PWY-2002
isoleucine metabolism
-
-
isoprene biosynthesis II (engineered)
-
-
PWY-7391
isoprenoid biosynthesis
-
-
isopropanol biosynthesis (engineered)
-
-
PWY-6876
Isoquinoline alkaloid biosynthesis
-
-
itaconate biosynthesis I
-
-
PWY-5750
itaconate degradation
-
-
PWY-5749
jadomycin biosynthesis
-
-
PWY-6679
jasmonic acid biosynthesis
-
-
PWY-735
juniperonate biosynthesis
-
-
PWY-7619
justicidin B biosynthesis
-
-
PWY-6824
juvenile hormone III biosynthesis I
-
-
PWY-6575
juvenile hormone III biosynthesis II
-
-
PWY-6650
Kdo transfer to lipid IVA (Brucella)
-
-
PWY2B4Q-6
Kdo transfer to lipid IVA (E. coli)
-
-
KDOSYN-PWY
Kdo transfer to lipid IVA (generic)
-
-
PWY-8284
Kdo transfer to lipid IVA (H. pylori)
-
-
PWY2DNV-1
Kdo transfer to lipid IVA (Haemophilus)
-
-
PWY-7675
Kdo transfer to lipid IVA (P. gingivalis)
-
-
PWY-8246
Kdo transfer to lipid IVA (P. putida)
-
-
PWY-8074
Kdo transfer to lipid IVA (Vibrio cholerae serogroup O1 El Tor)
-
-
PWY-8284-1
Kdo8N transfer to lipid IVA
-
-
PWY-7676
ketogenesis
-
-
PWY66-367
L-alanine biosynthesis I
-
-
ALANINE-VALINESYN-PWY
L-alanine biosynthesis II
-
-
ALANINE-SYN2-PWY
L-alanine degradation I
-
-
ALADEG-PWY
L-alanine degradation II (to D-lactate)
-
-
ALACAT2-PWY
L-alanine degradation III
-
-
ALANINE-DEG3-PWY
L-alanine degradation IV
-
-
PWY1-2
L-alanine degradation V (oxidative Stickland reaction)
-
-
PWY-8189
L-alanine degradation VI (reductive Stickland reaction)
-
-
PWY-8188
L-arabinose degradation II
-
-
PWY-5515
L-arabinose degradation IV
-
-
PWY-7295
L-arginine biosynthesis I (via L-ornithine)
-
-
ARGSYN-PWY
L-arginine biosynthesis II (acetyl cycle)
-
-
ARGSYNBSUB-PWY
L-arginine biosynthesis III (via N-acetyl-L-citrulline)
-
-
PWY-5154
L-arginine biosynthesis IV (archaea)
-
-
PWY-7400
L-arginine degradation I (arginase pathway)
-
-
ARGASEDEG-PWY
L-arginine degradation II (AST pathway)
-
-
AST-PWY
L-arginine degradation III (arginine decarboxylase/agmatinase pathway)
-
-
PWY0-823
L-arginine degradation IV (arginine decarboxylase/agmatine deiminase pathway)
-
-
ARGDEG-III-PWY
L-arginine degradation V (arginine deiminase pathway)
-
-
ARGDEGRAD-PWY
L-arginine degradation VI (arginase 2 pathway)
-
-
ARG-PRO-PWY
L-arginine degradation VII (arginase 3 pathway)
-
-
ARG-GLU-PWY
L-arginine degradation X (arginine monooxygenase pathway)
-
-
ARGDEG-V-PWY
L-arginine degradation XIII (reductive Stickland reaction)
-
-
PWY-8187
L-arginine degradation XIV (oxidative Stickland reaction)
-
-
PWY-6344
L-ascorbate biosynthesis IV (animals, D-glucuronate pathway)
-
-
PWY3DJ-35471
L-ascorbate biosynthesis VI (plants, myo-inositol pathway)
-
-
PWY-8142
L-ascorbate biosynthesis VIII (engineered pathway)
-
-
PWY-7165
L-ascorbate degradation I (bacterial, anaerobic)
-
-
PWY0-301
L-asparagine biosynthesis I
-
-
ASPARAGINE-BIOSYNTHESIS
L-asparagine biosynthesis II
-
-
ASPARAGINESYN-PWY
L-asparagine biosynthesis III (tRNA-dependent)
-
-
PWY490-4
L-asparagine degradation I
-
-
ASPARAGINE-DEG1-PWY
L-asparagine degradation II
-
-
PWY-4002
L-asparagine degradation III (mammalian)
-
-
ASPARAGINE-DEG1-PWY-1
L-aspartate biosynthesis
-
-
ASPARTATESYN-PWY
L-aspartate degradation I
-
-
ASPARTATE-DEG1-PWY
L-aspartate degradation II (aerobic)
-
-
PWY-8291
L-aspartate degradation III (anaerobic)
-
-
PWY-8294
L-carnitine degradation II
-
-
PWY-3641
L-citrulline biosynthesis
-
-
CITRULBIO-PWY
L-citrulline degradation
-
-
CITRULLINE-DEG-PWY
L-cysteine biosynthesis I
-
-
CYSTSYN-PWY
L-cysteine biosynthesis III (from L-homocysteine)
-
-
HOMOCYSDEGR-PWY
L-cysteine biosynthesis IX (Trichomonas vaginalis)
-
-
PWY-8010
L-cysteine biosynthesis VI (reverse transsulfuration)
-
-
PWY-I9
L-cysteine biosynthesis VII (from S-sulfo-L-cysteine)
-
-
PWY-7870
L-cysteine degradation I
-
-
CYSTEINE-DEG-PWY
L-cysteine degradation III
-
-
PWY-5329
L-dopa and L-dopachrome biosynthesis
-
-
PWY-6481
L-dopa degradation I (mammalian)
-
-
PWY-6334
L-dopa degradation II (bacterial)
-
-
PWY-8110
L-fucose degradation I
-
-
FUCCAT-PWY
L-glutamate biosynthesis I
-
-
GLUTSYN-PWY
L-glutamate biosynthesis II
-
-
GLUTAMATE-SYN2-PWY
L-glutamate biosynthesis III
-
-
GLUTSYNIII-PWY
L-glutamate degradation I
-
-
GLUTAMATE-DEG1-PWY
L-glutamate degradation II
-
-
GLUTDEG-PWY
L-glutamate degradation IX (via 4-aminobutanoate)
-
-
PWY0-1305
L-glutamate degradation V (via hydroxyglutarate)
-
-
P162-PWY
L-glutamate degradation VI (to pyruvate)
-
-
PWY-5087
L-glutamate degradation VII (to butanoate)
-
-
GLUDEG-II-PWY
L-glutamate degradation X
-
-
PWY-5766
L-glutamate degradation XI (reductive Stickland reaction)
-
-
PWY-8190
L-glutamine biosynthesis I
-
-
GLNSYN-PWY
L-glutamine degradation I
-
-
GLUTAMINDEG-PWY
L-histidine degradation I
-
-
HISDEG-PWY
L-histidine degradation II
-
-
PWY-5028
L-histidine degradation III
-
-
PWY-5030
L-histidine degradation V
-
-
PWY-5031
L-histidine degradation VI
-
-
HISHP-PWY
L-homophenylalanine biosynthesis
-
-
PWY-7275
L-homoserine biosynthesis
-
-
HOMOSERSYN-PWY
L-isoleucine biosynthesis I (from threonine)
-
-
ILEUSYN-PWY
L-isoleucine biosynthesis II
-
-
PWY-5101
L-isoleucine biosynthesis III
-
-
PWY-5103
L-isoleucine biosynthesis IV
-
-
PWY-5104
L-isoleucine biosynthesis V
-
-
PWY-5108
L-isoleucine degradation I
-
-
ILEUDEG-PWY
L-isoleucine degradation II
-
-
PWY-5078
L-isoleucine degradation III (oxidative Stickland reaction)
-
-
PWY-8184
L-lactaldehyde degradation
-
-
L-leucine biosynthesis
-
-
LEUSYN-PWY
L-leucine degradation I
-
-
LEU-DEG2-PWY
L-leucine degradation II
-
-
PWY-5075
L-leucine degradation III
-
-
PWY-5076
L-leucine degradation IV (reductive Stickland reaction)
-
-
PWY-7767
L-leucine degradation V (oxidative Stickland reaction)
-
-
PWY-8185
L-lysine biosynthesis I
-
-
DAPLYSINESYN-PWY
L-lysine biosynthesis II
-
-
PWY-2941
L-lysine biosynthesis III
-
-
PWY-2942
L-lysine biosynthesis IV
-
-
LYSINE-AMINOAD-PWY
L-lysine biosynthesis V
-
-
PWY-3081
L-lysine biosynthesis VI
-
-
PWY-5097
L-lysine degradation I
-
-
PWY0-461
L-lysine degradation II (L-pipecolate pathway)
-
-
PWY66-425
L-lysine degradation V
-
-
PWY-5283
L-lysine degradation X
-
-
PWY-6328
L-lysine degradation XI
-
-
LYSINE-DEG1-PWY
L-lysine fermentation to acetate and butanoate
-
-
P163-PWY
L-malate degradation II
-
-
PWY-7686
L-methionine biosynthesis I
-
-
HOMOSER-METSYN-PWY
L-methionine biosynthesis II
-
-
PWY-702
L-methionine biosynthesis III
-
-
HSERMETANA-PWY
L-methionine biosynthesis IV
-
-
PWY-7977
L-methionine degradation I (to L-homocysteine)
-
-
METHIONINE-DEG1-PWY
L-methionine degradation III
-
-
PWY-5082
L-methionine salvage cycle II (plants)
-
-
PWY-7270
L-methionine salvage from L-homocysteine
-
-
ADENOSYLHOMOCYSCAT-PWY
L-Ndelta-acetylornithine biosynthesis
-
-
PWY-6922
L-nicotianamine biosynthesis
-
-
PWY-5957
L-ornithine biosynthesis II
-
-
ARGININE-SYN4-PWY
L-ornithine degradation I (L-proline biosynthesis)
-
-
ORN-AMINOPENTANOATE-CAT-PWY
L-phenylalanine biosynthesis I
-
-
PHESYN
L-phenylalanine biosynthesis II
-
-
PWY-3462
L-phenylalanine degradation I (aerobic)
-
-
PHENYLALANINE-DEG1-PWY
L-phenylalanine degradation II (anaerobic)
-
-
ANAPHENOXI-PWY
L-phenylalanine degradation III
-
-
PWY-5079
L-phenylalanine degradation IV (mammalian, via side chain)
-
-
PWY-6318
L-phenylalanine degradation V
-
-
PWY-7158
L-phenylalanine degradation VI (reductive Stickland reaction)
-
-
PWY-8014
L-proline biosynthesis I (from L-glutamate)
-
-
PROSYN-PWY
L-proline biosynthesis II (from arginine)
-
-
PWY-4981
L-proline biosynthesis III (from L-ornithine)
-
-
PWY-3341
L-proline biosynthesis IV
-
-
PWY-4281
L-proline degradation I
-
-
PROUT-PWY
L-pyrrolysine biosynthesis
-
-
PWY-6994
L-selenocysteine biosynthesis I (bacteria)
-
-
PWY0-901
L-selenocysteine biosynthesis II (archaea and eukaryotes)
-
-
PWY-6281
L-serine biosynthesis I
-
-
SERSYN-PWY
L-serine biosynthesis II
-
-
PWY-8011
L-threonine degradation I
-
-
PWY-5437
L-threonine degradation II
-
-
THREONINE-DEG2-PWY
L-threonine degradation III (to methylglyoxal)
-
-
THRDLCTCAT-PWY
L-threonine degradation IV
-
-
PWY-5436
L-threonine degradation V
-
-
PWY66-428
L-tryptophan biosynthesis
-
-
TRPSYN-PWY
L-tryptophan degradation I (via anthranilate)
-
-
TRPCAT-PWY
L-tryptophan degradation IV (via indole-3-lactate)
-
-
TRPKYNCAT-PWY
L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde
-
-
PWY-5651
L-tryptophan degradation V (side chain pathway)
-
-
PWY-3162
L-tryptophan degradation VI (via tryptamine)
-
-
PWY-3181
L-tryptophan degradation VIII (to tryptophol)
-
-
PWY-5081
L-tryptophan degradation X (mammalian, via tryptamine)
-
-
PWY-6307
L-tryptophan degradation XI (mammalian, via kynurenine)
-
-
PWY-6309
L-tryptophan degradation XII (Geobacillus)
-
-
PWY-6505
L-tryptophan degradation XIII (reductive Stickland reaction)
-
-
PWY-8017
L-tyrosine biosynthesis I
-
-
TYRSYN
L-tyrosine biosynthesis II
-
-
PWY-3461
L-tyrosine biosynthesis III
-
-
PWY-6120
L-tyrosine biosynthesis IV
-
-
PWY-6134
L-tyrosine degradation I
-
-
TYRFUMCAT-PWY
L-tyrosine degradation II
-
-
PWY-5151
L-tyrosine degradation III
-
-
PWY3O-4108
L-tyrosine degradation IV (to 4-methylphenol)
-
-
PWY-7514
L-tyrosine degradation V (reductive Stickland reaction)
-
-
PWY-8016
L-valine biosynthesis
-
-
VALSYN-PWY
L-valine degradation I
-
-
VALDEG-PWY
L-valine degradation II
-
-
PWY-5057
L-valine degradation III (oxidative Stickland reaction)
-
-
PWY-8183
lactate fermentation to acetate, CO2 and hydrogen (Desulfovibrionales)
-
-
PWY-8377
lacto-series glycosphingolipids biosynthesis
-
-
PWY-7839
lactose degradation III
-
-
BGALACT-PWY
lanosterol biosynthesis
-
-
PWY-6132
leukotriene biosynthesis
-
-
PWY66-375
Limonene and pinene degradation
-
-
limonene degradation IV (anaerobic)
-
-
PWY-8029
linalool biosynthesis I
-
-
PWY-7182
linamarin degradation
-
-
PWY-3121
linezolid resistance
-
-
PWY-6828
linoleate biosynthesis I (plants)
-
-
PWY-5995
linoleate biosynthesis II (animals)
-
-
PWY-6001
linoleate metabolites biosynthesis
-
-
PWY-8395
Linoleic acid metabolism
-
-
linustatin bioactivation
-
-
PWY-7091
lipid A-core biosynthesis (E. coli K-12)
-
-
LIPA-CORESYN-PWY
lipid IVA biosynthesis (2,3-diamino-2,3-dideoxy-D-glucopyranose-containing)
-
-
PWY2B4Q-4
lipid IVA biosynthesis (E. coli)
-
-
NAGLIPASYN-PWY
lipid IVA biosynthesis (generic)
-
-
PWY-8283
lipid IVA biosynthesis (H. pylori)
-
-
PWYI-14
lipid IVA biosynthesis (P. gingivalis)
-
-
PWY-8245
lipid IVA biosynthesis (P. putida)
-
-
PWY-8073
lipid IVA biosynthesis (Vibrio cholerae serogroup O1 El Tor)
-
-
PWY2G6Z-2
Lipopolysaccharide biosynthesis
-
-
lipoprotein posttranslational modification
-
-
PWY-7884
lipoxin biosynthesis
-
-
PWY66-392
long chain fatty acid ester synthesis (engineered)
-
-
PWY-6873
long-chain fatty acid activation
-
-
PWY-5143
lotaustralin degradation
-
-
PWY-6002
lupanine biosynthesis
-
-
PWY-5468
lupulone and humulone biosynthesis
-
-
PWY-5132
luteolin triglucuronide degradation
-
-
PWY-7445
macrolide antibiotic biosynthesis
-
-
malate/L-aspartate shuttle pathway
-
-
MALATE-ASPARTATE-SHUTTLE-PWY
maltose degradation
-
-
MALTOSECAT-PWY
manganese oxidation I
-
-
PWY-6591
mannitol biosynthesis
-
-
PWY-3881
mannitol cycle
-
-
PWY-6531
mannitol degradation I
-
-
MANNIDEG-PWY
mannitol degradation II
-
-
PWY-3861
Mannose type O-glycan biosynthesis
-
-
maresin biosynthesis
-
-
PWY-8356
matairesinol biosynthesis
-
-
PWY-5466
melatonin degradation I
-
-
PWY-6398
melatonin degradation II
-
-
PWY-6399
melibiose degradation
-
-
PWY0-1301
metabolism of amino sugars and derivatives
-
-
metabolism of disaccharids
-
-
Metabolism of xenobiotics by cytochrome P450
-
-
Methanobacterium thermoautotrophicum biosynthetic metabolism
-
-
PWY-6146
methanofuran biosynthesis
-
-
PWY-5254
methanogenesis from acetate
-
-
METH-ACETATE-PWY
methanogenesis from CO2
-
-
methanogenesis from H2 and CO2
-
-
METHANOGENESIS-PWY
methanol oxidation to formaldehyde IV
-
-
PWY-5506
methiin metabolism
-
-
PWY-7614
methionine metabolism
-
-
methoxylated aromatic compound degradation II
-
-
PWY-8305
methyl indole-3-acetate interconversion
-
-
PWY-6303
methyl ketone biosynthesis (engineered)
-
-
PWY-7007
methyl parathion degradation
-
-
PWY-5489
methyl phomopsenoate biosynthesis
-
-
PWY-7721
methyl tert-butyl ether degradation
-
-
PWY-7779
methyl-coenzyme M oxidation to CO2
-
-
PWY-5209
methyl-coenzyme M reduction to methane
-
-
METHFORM-PWY
methylerythritol phosphate pathway I
-
-
NONMEVIPP-PWY
methylerythritol phosphate pathway II
-
-
PWY-7560
methylgallate degradation
-
-
METHYLGALLATE-DEGRADATION-PWY
methylglyoxal degradation
-
-
methylglyoxal degradation I
-
-
PWY-5386
methylglyoxal degradation III
-
-
PWY-5453
methylglyoxal degradation VI
-
-
MGLDLCTANA-PWY
methylglyoxal degradation VIII
-
-
PWY-5386-1
methylsalicylate degradation
-
-
PWY18C3-24
methylwyosine biosynthesis
-
-
PWY-7285
mevalonate degradation
-
-
PWY-5074
mevalonate metabolism
-
-
mevalonate pathway I (eukaryotes and bacteria)
-
-
PWY-922
mevalonate pathway II (haloarchaea)
-
-
PWY-6174
mevalonate pathway III (Thermoplasma)
-
-
PWY-7524
mevalonate pathway IV (archaea)
-
-
PWY-8125
Microbial metabolism in diverse environments
-
-
mineralocorticoid biosynthesis
-
-
PWY66-382
mitochondrial L-carnitine shuttle
-
-
PWY-6111
mitochondrial NADPH production (yeast)
-
-
PWY-7269
mixed acid fermentation
-
-
FERMENTATION-PWY
mono-trans, poly-cis decaprenyl phosphate biosynthesis
-
-
PWY-6383
monoacylglycerol metabolism (yeast)
-
-
PWY-7420
Monobactam biosynthesis
-
-
Monoterpenoid biosynthesis
-
-
mRNA capping I
-
-
PWY-7375
mRNA capping II
-
-
PWY-7379
mucin core 1 and core 2 O-glycosylation
-
-
PWY-7433
mucin core 3 and core 4 O-glycosylation
-
-
PWY-7435
Mucin type O-glycan biosynthesis
-
-
mupirocin biosynthesis
-
-
PWY-8012
muropeptide degradation
-
-
PWY0-1546
mycobactin biosynthesis
-
-
PWY185E-1
mycolate biosynthesis
-
-
PWYG-321
mycolyl-arabinogalactan-peptidoglycan complex biosynthesis
-
-
PWY-6397
mycothiol biosynthesis
-
-
PWY1G-0
myo-inositol biosynthesis
N-3-oxalyl-L-2,3-diaminopropanoate biosynthesis
-
-
PWY-8071
N-acetylglucosamine degradation I
-
-
GLUAMCAT-PWY
N-acetylneuraminate and N-acetylmannosamine degradation I
-
-
PWY0-1324
N-acetylneuraminate and N-acetylmannosamine degradation II
-
-
PWY-7581
N-Glycan biosynthesis
-
-
N-hydroxy-L-pipecolate biosynthesis
-
-
PWY-7861
NAD biosynthesis from nicotinamide
-
-
NAD-BIOSYNTHESIS-III
NAD phosphorylation and dephosphorylation
-
-
NADPHOS-DEPHOS-PWY
NAD phosphorylation and transhydrogenation
-
-
NADPHOS-DEPHOS-PWY-1
NAD salvage (plants)
-
-
PWY-5381
NAD salvage pathway I (PNC VI cycle)
-
-
PYRIDNUCSAL-PWY
NAD salvage pathway III (to nicotinamide riboside)
-
-
NAD-BIOSYNTHESIS-II
NAD salvage pathway IV (from nicotinamide riboside)
-
-
PWY3O-4106
NAD salvage pathway V (PNC V cycle)
-
-
PWY3O-4107
NAD(P)/NADPH interconversion
-
-
PWY-5083
NADH to cytochrome bd oxidase electron transfer I
-
-
PWY0-1334
NADH to cytochrome bo oxidase electron transfer I
-
-
PWY0-1335
NADH to dimethyl sulfoxide electron transfer
-
-
PWY0-1348
NADH to fumarate electron transfer
-
-
PWY0-1336
NADP biosynthesis
-
-
PWY-8148
NADPH to cytochrome c oxidase via plastocyanin
-
-
PWY-8271
Naphthalene degradation
-
-
naringenin biosynthesis (engineered)
-
-
PWY-7397
neolacto-series glycosphingolipids biosynthesis
-
-
PWY-7841
neolinustatin bioactivation
-
-
PWY-7092
Neomycin, kanamycin and gentamicin biosynthesis
-
-
nepetalactone biosynthesis
-
-
PWY-8069
neurosporaxanthin biosynthesis
-
-
PWY-6681
Nicotinate and nicotinamide metabolism
-
-
nicotine degradation I (pyridine pathway)
-
-
P181-PWY
nicotine degradation IV
-
-
PWY66-201
nicotine degradation V
-
-
PWY66-221
nitrate reduction I (denitrification)
-
-
DENITRIFICATION-PWY
nitrate reduction II (assimilatory)
-
-
PWY-381
nitrate reduction IX (dissimilatory)
-
-
PWY0-1581
nitrate reduction V (assimilatory)
-
-
PWY-5675
nitrate reduction VI (assimilatory)
-
-
PWY490-3
nitrate reduction VII (denitrification)
-
-
PWY-6748
nitrate reduction X (dissimilatory, periplasmic)
-
-
PWY0-1584
nitric oxide biosynthesis II (mammals)
-
-
PWY-4983
nitrifier denitrification
-
-
PWY-7084
nitrite-dependent anaerobic methane oxidation
-
-
PWY-6523
nitrogen remobilization from senescing leaves
-
-
PWY-6549
Nitrotoluene degradation
-
-
nocardicin A biosynthesis
-
-
PWY-7797
noradrenaline and adrenaline degradation
-
-
PWY-6342
norspermidine biosynthesis
-
-
PWY-6562
noscapine biosynthesis
-
-
PWY-7138
Novobiocin biosynthesis
-
-
nucleoside and nucleotide degradation (archaea)
-
-
PWY-5532
O-antigen biosynthesis
-
-
O-antigen building blocks biosynthesis (E. coli)
-
-
OANTIGEN-PWY
O-Antigen nucleotide sugar biosynthesis
-
-
o-diquinones biosynthesis
-
-
PWY-6752
octanoyl-[acyl-carrier protein] biosynthesis (mitochondria, yeast)
-
-
PWY-7388
octopamine biosynthesis
-
-
PWY-7297
odd iso-branched-chain fatty acid biosynthesis
-
-
PWY-8174
oleandomycin activation/inactivation
-
-
PWY-6972
oleate beta-oxidation
-
-
PWY0-1337
oleate beta-oxidation (isomerase-dependent, yeast)
-
-
PWY-7291
oleate beta-oxidation (reductase-dependent, yeast)
-
-
PWY-7307
oleate biosynthesis I (plants)
-
-
PWY-5147
oleate biosynthesis II (animals and fungi)
-
-
PWY-5996
oleate biosynthesis III (cyanobacteria)
-
-
PWY-7587
oleate biosynthesis IV (anaerobic)
-
-
PWY-7664
One carbon pool by folate
-
-
ophiobolin F biosynthesis
-
-
PWY-7720
ophthalmate biosynthesis
-
-
PWY-8043
Other glycan degradation
-
-
Other types of O-glycan biosynthesis
-
-
oxalate degradation III
-
-
PWY-6696
oxalate degradation VI
-
-
PWY-7985
oxidative decarboxylation of pyruvate
-
-
Oxidative phosphorylation
-
-
oxidative phosphorylation
-
-
palmitate biosynthesis
-
-
palmitate biosynthesis I (type I fatty acid synthase)
-
-
PWY-5994
palmitate biosynthesis II (type II fatty acid synthase)
-
-
PWY-5971
palmitate biosynthesis III
-
-
PWY-8279
palmitoleate biosynthesis I (from (5Z)-dodec-5-enoate)
-
-
PWY-6282
palmitoleate biosynthesis III (cyanobacteria)
-
-
PWY-7589
palmitoleate biosynthesis IV (fungi and animals)
-
-
PWY3O-1801
palmitoyl ethanolamide biosynthesis
-
-
PWY-8055
Pantothenate and CoA biosynthesis
-
-
pantothenate biosynthesis
-
-
paraoxon degradation
-
-
PWY-5490
parathion degradation
-
-
PARATHION-DEGRADATION-PWY
partial TCA cycle (obligate autotrophs)
-
-
PWY-5913
paspaline biosynthesis
-
-
PWY-7492
patulin biosynthesis
-
-
PWY-7490
pederin biosynthesis
-
-
PWY-8049
Penicillin and cephalosporin biosynthesis
-
-
pentachlorophenol degradation
-
-
PCPDEG-PWY
Pentose and glucuronate interconversions
-
-
Pentose phosphate pathway
-
-
pentose phosphate pathway
-
-
pentose phosphate pathway (non-oxidative branch) I
-
-
NONOXIPENT-PWY
pentose phosphate pathway (non-oxidative branch) II
-
-
PWY-8178
pentose phosphate pathway (oxidative branch) I
-
-
OXIDATIVEPENT-PWY
pentose phosphate pathway (partial)
-
-
P21-PWY
peptido-conjugates in tissue regeneration biosynthesis
-
-
PWY-8355
Peptidoglycan biosynthesis
-
-
peptidoglycan biosynthesis
-
-
peptidoglycan biosynthesis I (meso-diaminopimelate containing)
-
-
PEPTIDOGLYCANSYN-PWY
peptidoglycan biosynthesis II (staphylococci)
-
-
PWY-5265
peptidoglycan biosynthesis III (mycobacteria)
-
-
PWY-6385
peptidoglycan biosynthesis IV (Enterococcus faecium)
-
-
PWY-6471
peptidoglycan biosynthesis V (beta-lactam resistance)
-
-
PWY-6470
peptidoglycan maturation (meso-diaminopimelate containing)
-
-
PWY0-1586
peptidoglycan recycling I
-
-
PWY0-1261
peptidoglycan recycling II
-
-
PWY-7883
periplasmic disulfide bond formation
-
-
PWY0-1599
petrobactin biosynthesis
-
-
PWY-6289
petroselinate biosynthesis
-
-
PWY-5367
Phenazine biosynthesis
-
-
phenylacetate degradation (aerobic)
-
-
phenylacetate degradation I (aerobic)
-
-
PWY0-321
Phenylalanine metabolism
-
-
phenylalanine metabolism
-
-
Phenylalanine, tyrosine and tryptophan biosynthesis
-
-
phenylethanol biosynthesis
-
-
PWY-5751
phenylethylamine degradation I
-
-
2PHENDEG-PWY
phenylpropanoid biosynthesis
-
-
PWY-361
Phenylpropanoid biosynthesis
-
-
phenylpropanoid biosynthesis
-
-
pheomelanin biosynthesis
-
-
PWY-7917
phloridzin biosynthesis
-
-
PWY-6515
phosalacine biosynthesis
-
-
PWY-7769
phosphate acquisition
-
-
PWY-6348
phosphatidate biosynthesis (yeast)
-
-
PWY-7411
phosphatidate metabolism, as a signaling molecule
-
-
PWY-7039
phosphatidylcholine acyl editing
-
-
PWY-6803
phosphatidylcholine biosynthesis I
-
-
PWY3O-450
phosphatidylcholine biosynthesis II
-
-
PWY4FS-2
phosphatidylcholine biosynthesis III
-
-
PWY4FS-3
phosphatidylcholine biosynthesis IV
-
-
PWY4FS-4
phosphatidylcholine biosynthesis V
-
-
PWY-6825
phosphatidylcholine biosynthesis VII
-
-
PWY-7470
phosphatidylcholine resynthesis via glycerophosphocholine
-
-
PWY-7367
phosphatidylethanolamine biosynthesis II
-
-
PWY4FS-6
phosphatidylethanolamine bioynthesis
-
-
phosphatidylinositol biosynthesis I (bacteria)
-
-
PWY-6580
phosphatidylinositol biosynthesis II (eukaryotes)
-
-
PWY-7625
phosphatidylserine and phosphatidylethanolamine biosynthesis I
-
-
PWY-5669
phosphinothricin tripeptide biosynthesis
-
-
PWY-6322
phospholipases
-
-
LIPASYN-PWY
phospholipid desaturation
-
-
PWY-762
phospholipid remodeling (phosphatidate, yeast)
-
-
PWY-7417
phospholipid remodeling (phosphatidylcholine, yeast)
-
-
PWY-7416
phospholipid remodeling (phosphatidylethanolamine, yeast)
-
-
PWY-7409
Phosphonate and phosphinate metabolism
-
-
phosphopantothenate biosynthesis I
-
-
PANTO-PWY
phosphopantothenate biosynthesis II
-
-
PWY-3961
photorespiration I
-
-
PWY-181
photorespiration II
-
-
PWY-8362
photorespiration III
-
-
PWY-8363
photosynthesis light reactions
-
-
PWY-101
photosynthetic 3-hydroxybutanoate biosynthesis (engineered)
-
-
PWY-7218
phytate degradation I
-
-
PWY-4702
phytate degradation II
-
-
PWY-4781
phytochelatins biosynthesis
-
-
PWY-6745
phytol degradation
-
-
PWY66-389
phytosterol biosynthesis (plants)
-
-
PWY-2541
pinitol biosynthesis I
-
-
PWY-6738
pinobanksin biosynthesis
-
-
PWY-5059
pinoresinol degradation
-
-
PWY-7982
plasmalogen biosynthesis I (aerobic)
-
-
PWY-7782
plasmalogen degradation
-
-
PWY-7783
plastoquinol-9 biosynthesis I
-
-
PWY-1581
platensimycin biosynthesis
-
-
PWY-8179
plaunotol biosynthesis
-
-
PWY-6691
poly(3-O-beta-D-glucopyranosyl-N-acetylgalactosamine 1-phosphate) wall teichoic acid biosynthesis
-
-
PWY-7819
poly(glycerol phosphate) wall teichoic acid biosynthesis
-
-
TEICHOICACID-PWY
poly(ribitol phosphate) wall teichoic acid biosynthesis I (B. subtilis)
-
-
PWY-7815
poly(ribitol phosphate) wall teichoic acid biosynthesis II (S. aureus)
-
-
PWY-7816
poly-hydroxy fatty acids biosynthesis
-
-
PWY-6710
polyhydroxybutanoate biosynthesis
-
-
PWY1-3
Polyketide sugar unit biosynthesis
-
-
polymyxin resistance
-
-
PWY0-1338
polyphosphate metabolism
-
-
PWY-8138
Porphyrin and chlorophyll metabolism
-
-
ppGpp metabolism
-
-
PPGPPMET-PWY
preQ0 biosynthesis
-
-
PWY-6703
Primary bile acid biosynthesis
-
-
procollagen hydroxylation and glycosylation
-
-
PWY-7894
progesterone biosynthesis
-
-
PWY-7299
propanethial S-oxide biosynthesis
-
-
PWY-5707
propanoate fermentation to 2-methylbutanoate
-
-
PWY-5109
Propanoate metabolism
-
-
propanoyl CoA degradation I
-
-
PROPIONMET-PWY
propanoyl-CoA degradation II
-
-
PWY-7574
propionate fermentation
-
-
protectin biosynthesis
-
-
PWY-8357
protective electron sinks in the thylakoid membrane (PSII to PTOX)
-
-
PWY1YI0-7
protein citrullination
-
-
PWY-4921
protein N-glycosylation (Haloferax volcanii)
-
-
PWY-7661
protein N-glycosylation initial phase (eukaryotic)
-
-
MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS
protein N-glycosylation processing phase (endoplasmic reticulum, yeast)
-
-
PWY-7918
protein N-glycosylation processing phase (plants and animals)
-
-
PWY-7919
protein NEDDylation
-
-
PWY-7899
protein O-mannosylation I (yeast)
-
-
PWY-7921
protein O-mannosylation II (mammals, core M1 and core M2)
-
-
PWY-7922
protein O-mannosylation III (mammals, core M3)
-
-
PWY-7979
protein S-nitrosylation and denitrosylation
-
-
PWY-7798
protein ubiquitination
-
-
PWY-7511
protocatechuate degradation I (meta-cleavage pathway)
-
-
P184-PWY
PRPP biosynthesis
-
-
PWY0-662
psilocybin biosynthesis
-
-
PWY-7936
purine deoxyribonucleosides degradation I
-
-
PWY-7179
purine deoxyribonucleosides degradation II
-
-
PWY-7179-1
purine deoxyribonucleosides salvage
-
-
PWY-7224
purine nucleobases degradation I (anaerobic)
-
-
P164-PWY
purine nucleobases degradation II (anaerobic)
-
-
PWY-5497
purine ribonucleosides degradation
-
-
PWY0-1296
putrescine biosynthesis I
-
-
PWY-40
putrescine biosynthesis II
-
-
PWY-43
putrescine biosynthesis III
-
-
PWY-46
putrescine degradation III
-
-
PWY-0
pyridoxal 5'-phosphate salvage I
-
-
PLPSAL-PWY
pyridoxal 5'-phosphate salvage II (plants)
-
-
PWY-7204
pyrimidine deoxyribonucleosides degradation
-
-
PWY-7181
pyrimidine deoxyribonucleosides salvage
-
-
PWY-7199
pyrimidine deoxyribonucleotide phosphorylation
-
-
PWY-7197
pyrimidine deoxyribonucleotides biosynthesis from CTP
-
-
PWY-7210
pyrimidine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7184
pyrimidine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7187
pyrimidine deoxyribonucleotides de novo biosynthesis III
-
-
PWY-6545
pyrimidine deoxyribonucleotides de novo biosynthesis IV
-
-
PWY-7198
pyrimidine deoxyribonucleotides dephosphorylation
-
-
PWY-7206
Pyrimidine metabolism
-
-
pyrimidine metabolism
-
-
pyrimidine nucleobases salvage II
-
-
PWY-7194
pyrimidine ribonucleosides degradation
-
-
PWY0-1295
pyrimidine ribonucleosides salvage I
-
-
PWY-7193
pyrimidine ribonucleosides salvage II
-
-
PWY-6556
pyrimidine ribonucleosides salvage III
-
-
PWY-7195
pyruvate decarboxylation to acetyl CoA I
-
-
PYRUVDEHYD-PWY
pyruvate decarboxylation to acetyl CoA II
-
-
PWY-6970
pyruvate decarboxylation to acetyl CoA III
-
-
PWY-8275
pyruvate fermentation to (R)-acetoin I
-
-
PWY-5938
pyruvate fermentation to (R)-acetoin II
-
-
PWY-5939
pyruvate fermentation to (R)-lactate
-
-
PWY-8274
pyruvate fermentation to (S)-acetoin
-
-
PWY-6389
pyruvate fermentation to (S)-lactate
-
-
PWY-5481
pyruvate fermentation to acetate I
-
-
P142-PWY
pyruvate fermentation to acetate II
-
-
PWY-5482
pyruvate fermentation to acetate III
-
-
PWY-5483
pyruvate fermentation to acetate IV
-
-
PWY-5485
pyruvate fermentation to acetate V
-
-
PWY-5537
pyruvate fermentation to acetate VI
-
-
PWY-5538
pyruvate fermentation to acetate VII
-
-
PWY-5600
pyruvate fermentation to acetate VIII
-
-
PWY-5768
pyruvate fermentation to acetoin III
-
-
PWY3O-440
pyruvate fermentation to acetone
-
-
PWY-6588
pyruvate fermentation to butanoate
-
-
CENTFERM-PWY
pyruvate fermentation to butanol I
-
-
PWY-6583
pyruvate fermentation to butanol II (engineered)
-
-
PWY-6883
pyruvate fermentation to ethanol I
-
-
PWY-5480
pyruvate fermentation to ethanol II
-
-
PWY-5486
pyruvate fermentation to ethanol III
-
-
PWY-6587
pyruvate fermentation to hexanol (engineered)
-
-
PWY-6863
pyruvate fermentation to isobutanol (engineered)
-
-
PWY-7111
pyruvate fermentation to propanoate I
-
-
P108-PWY
pyruvate fermentation to propanoate II (acrylate pathway)
-
-
PWY-5494
quinoxaline-2-carboxylate biosynthesis
-
-
PWY-7734
Rapoport-Luebering glycolytic shunt
-
-
PWY-6405
reactive oxygen species degradation
-
-
DETOX1-PWY-1
reductive acetyl coenzyme A pathway
-
-
reductive acetyl coenzyme A pathway I (homoacetogenic bacteria)
-
-
CODH-PWY
reductive acetyl coenzyme A pathway II (autotrophic methanogens)
-
-
PWY-7784
reductive glycine pathway of autotrophic CO2 fixation
-
-
PWY-8303
reductive monocarboxylic acid cycle
-
-
PWY-5493
reductive TCA cycle I
-
-
P23-PWY
reductive TCA cycle II
-
-
PWY-5392
resolvin D biosynthesis
-
-
PWY66-397
retinoate biosynthesis I
-
-
PWY-6872
retinol biosynthesis
-
-
PWY-6857
Riboflavin metabolism
-
-
ricinoleate biosynthesis
-
-
PWY-7618
roseoflavin biosynthesis
-
-
PWY-7863
rosmarinic acid biosynthesis I
-
-
PWY-5048
rosmarinic acid biosynthesis II
-
-
PWY-5049
roxarsone degradation I
-
-
PWY-8260
Rubisco shunt
-
-
PWY-5723
S-(6-hydroxy-4-methylhexan-4-yl)-L-cysteinylglycine biosynthesis
-
-
PWY-8301
S-(6-hydroxy-4-methylhexan-4-yl)-L-cysteinylglycine degradation
-
-
PWY-8302
S-adenosyl-L-methionine biosynthesis
-
-
SAM-PWY
S-adenosyl-L-methionine salvage I
-
-
PWY-6151
S-adenosyl-L-methionine salvage II
-
-
PWY-5041
S-methyl-5'-thioadenosine degradation I
-
-
PWY-6754
S-methyl-5'-thioadenosine degradation II
-
-
PWY-6756
S-methyl-5'-thioadenosine degradation IV
-
-
PWY0-1391
S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation I
-
-
PWY-4361
salicylate biosynthesis I
-
-
PWY-6406
salicylate biosynthesis II
-
-
PWY-8321
salidroside biosynthesis
-
-
PWY-6802
salinosporamide A biosynthesis
-
-
PWY-6627
Salmonella enterica serotype O:13 O antigen biosynthesis
-
-
PWY-8230
Salmonella enterica serotype O:54 O antigen biosynthesis
-
-
PWY-8204
saponin biosynthesis II
-
-
PWY-5756
sciadonate biosynthesis
-
-
PWY-6598
secologanin and strictosidine biosynthesis
-
-
PWY-5290
Secondary bile acid biosynthesis
-
-
sedoheptulose bisphosphate bypass
-
-
PWY0-1517
selenate reduction
-
-
PWY-6932
seleno-amino acid biosynthesis (plants)
-
-
PWY-6936
seleno-amino acid detoxification and volatilization I
-
-
PWY-6931
seleno-amino acid detoxification and volatilization III
-
-
PWY-6933
Selenocompound metabolism
-
-
selenocysteine biosynthesis
-
-
serine racemization
-
-
PWY-8140
serotonin and melatonin biosynthesis
-
-
PWY-6030
serotonin degradation
-
-
PWY-6313
sesamin biosynthesis
-
-
PWY-5469
Sesquiterpenoid and triterpenoid biosynthesis
-
-
sinapate ester biosynthesis
-
-
PWY-3301
sitosterol degradation to androstenedione
-
-
PWY-6948
sophorosyloxydocosanoate deacetylation
-
-
SOPHOROSYLOXYDOCOSANOATE-DEG-PWY
sorbitol biosynthesis II
-
-
PWY-5530
sorgoleone biosynthesis
-
-
PWY-5987
spermidine biosynthesis I
-
-
BSUBPOLYAMSYN-PWY
spermidine biosynthesis II
-
-
PWY-6559
spermidine biosynthesis III
-
-
PWY-6834
spermine and spermidine degradation I
-
-
PWY-6117
spermine biosynthesis
-
-
ARGSPECAT-PWY
sphingolipid biosynthesis (mammals)
-
-
PWY-7277
sphingolipid biosynthesis (plants)
-
-
PWY-5129
sphingolipid biosynthesis (yeast)
-
-
SPHINGOLIPID-SYN-PWY
Sphingolipid metabolism
-
-
sphingomyelin metabolism
-
-
PWY3DJ-11281
sphingosine and sphingosine-1-phosphate metabolism
-
-
PWY3DJ-11470
sphingosine metabolism
-
-
Spodoptera littoralis pheromone biosynthesis
-
-
PWY-7656
sporopollenin precursors biosynthesis
-
-
PWY-6733
stachyose degradation
-
-
PWY-6527
staphyloxanthin biosynthesis
-
-
PWY-5875
Starch and sucrose metabolism
-
-
starch biosynthesis
-
-
PWY-622
starch degradation I
-
-
PWY-842
starch degradation II
-
-
PWY-6724
starch degradation III
-
-
PWY-6731
starch degradation V
-
-
PWY-6737
stearate biosynthesis I (animals)
-
-
PWY-5972
stearate biosynthesis II (bacteria and plants)
-
-
PWY-5989
stearate biosynthesis III (fungi)
-
-
PWY3O-355
stearate biosynthesis IV
-
-
PWY-8280
stellatic acid biosynthesis
-
-
PWY-7736
Steroid hormone biosynthesis
-
-
sterol biosynthesis (methylotrophs)
-
-
PWY-8026
sterol:steryl ester interconversion (yeast)
-
-
PWY-7424
stigma estolide biosynthesis
-
-
PWY-6453
streptomycin biosynthesis
-
-
PWY-5940
Streptomycin biosynthesis
-
-
streptorubin B biosynthesis
-
-
PWY1A0-6120
suberin monomers biosynthesis
-
-
PWY-1121
succinate fermentation to butanoate
-
-
PWY-5677
succinate to chytochrome c oxidase via cytochrome c6
-
-
PWY1YI0-2
succinate to cytochrome bd oxidase electron transfer
-
-
PWY0-1353
succinate to cytochrome bo oxidase electron transfer
-
-
PWY0-1329
succinate to cytochrome c oxidase via plastocyanin
-
-
PWY1YI0-3
succinate to plastoquinol oxidase
-
-
PWY1YI0-8
sucrose biosynthesis I (from photosynthesis)
-
-
SUCSYN-PWY
sucrose biosynthesis II
-
-
PWY-7238
sucrose biosynthesis III
-
-
PWY-7347
sucrose degradation I (sucrose phosphotransferase)
-
-
SUCUTIL-PWY
sucrose degradation II (sucrose synthase)
-
-
PWY-3801
sucrose degradation III (sucrose invertase)
-
-
PWY-621
sucrose degradation IV (sucrose phosphorylase)
-
-
PWY-5384
sucrose degradation V (sucrose alpha-glucosidase)
-
-
PWY66-373
sucrose degradation VII (sucrose 3-dehydrogenase)
-
-
SUCROSEUTIL2-PWY
sulfate activation for sulfonation
-
-
PWY-5340
sulfated glycosaminoglycan metabolism
-
-
sulfide oxidation I (to sulfur globules)
-
-
P222-PWY
sulfide oxidation III (to sulfite)
-
-
PWY-5285
sulfide oxidation IV (mitochondria)
-
-
PWY-7927
sulfite oxidation I
-
-
PWY-5276
sulfite oxidation II
-
-
PWY-5279
sulfite oxidation III
-
-
PWY-5278
sulfite oxidation IV (sulfite oxidase)
-
-
PWY-5326
sulfoacetaldehyde degradation I
-
-
PWY-1281
sulfolactate degradation II
-
-
PWY-6637
sulfolactate degradation III
-
-
PWY-6638
sulfopterin metabolism
-
-
sulfur volatiles biosynthesis
-
-
PWY-6736
superoxide radicals degradation
-
-
DETOX1-PWY
superpathway of 5-aminoimidazole ribonucleotide biosynthesis
-
-
PWY-6277
superpathway of coenzyme A biosynthesis III (mammals)
-
-
COA-PWY-1
superpathway of dimethylsulfoniopropanoate degradation
-
-
PWY-6049
superpathway of fatty acid biosynthesis initiation
-
-
FASYN-INITIAL-PWY
superpathway of fermentation (Chlamydomonas reinhardtii)
-
-
PWY4LZ-257
superpathway of glucose and xylose degradation
-
-
PWY-6901
superpathway of glycolysis and the Entner-Doudoroff pathway
-
-
GLYCOLYSIS-E-D
superpathway of glycolysis, pyruvate dehydrogenase, TCA, and glyoxylate bypass
-
-
GLYCOLYSIS-TCA-GLYOX-BYPASS
superpathway of glyoxylate cycle and fatty acid degradation
-
-
PWY-561
superpathway of L-aspartate and L-asparagine biosynthesis
-
-
ASPASN-PWY
superpathway of methylsalicylate metabolism
-
-
PWY18C3-25
superpathway of mycolate biosynthesis
-
-
PWY-6113
superpathway of ornithine degradation
-
-
ORNDEG-PWY
superpathway of phospholipid biosynthesis II (plants)
-
-
PHOSLIPSYN2-PWY
superpathway of photosynthetic hydrogen production
-
-
PWY-7731
superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli)
-
-
PWY0-166
superpathway of UDP-glucose-derived O-antigen building blocks biosynthesis
-
-
PWY-7328
syringate degradation
-
-
PWY-6339
Taurine and hypotaurine metabolism
-
-
taurine biosynthesis I
-
-
PWY-5331
taurine biosynthesis II
-
-
PWY-7850
taurine biosynthesis III
-
-
PWY-8359
TCA cycle I (prokaryotic)
-
-
TCA
TCA cycle II (plants and fungi)
-
-
PWY-5690
TCA cycle III (animals)
-
-
PWY66-398
TCA cycle IV (2-oxoglutarate decarboxylase)
-
-
P105-PWY
TCA cycle V (2-oxoglutarate synthase)
-
-
PWY-6969
TCA cycle VI (Helicobacter)
-
-
REDCITCYC
TCA cycle VII (acetate-producers)
-
-
PWY-7254
TCA cycle VIII (Chlamydia)
-
-
TCA-1
tea aroma glycosidic precursor bioactivation
-
-
PWY-7114
teichuronic acid biosynthesis (B. subtilis 168)
-
-
PWY-7820
terminal O-glycans residues modification (via type 2 precursor disaccharide)
-
-
PWY-7434
Terpenoid backbone biosynthesis
-
-
testosterone and androsterone degradation to androstendione (aerobic)
-
-
PWY-6943
tetracenomycin C biosynthesis
-
-
PWY-7485
tetradecanoate biosynthesis (mitochondria)
-
-
PWY66-430
tetrahydrofolate biosynthesis I
-
-
PWY-6614
tetrahydrofolate biosynthesis II
-
-
PWY2DNV-11
tetrahydrofolate metabolism
-
-
tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate
-
-
PWY-6613
tetrahydromonapterin biosynthesis
-
-
PWY0-1433
tetrahydropteridine recycling
-
-
PWY-8099
tetrapyrrole biosynthesis I (from glutamate)
-
-
PWY-5188
tetrapyrrole biosynthesis II (from glycine)
-
-
PWY-5189
the visual cycle I (vertebrates)
-
-
PWY-6861
theobromine biosynthesis I
-
-
PWY-5039
theophylline degradation
-
-
PWY-6999
thiamine diphosphate biosynthesis I (E. coli)
-
-
PWY-6894
thiamine diphosphate biosynthesis II (Bacillus)
-
-
PWY-6893
thiamine diphosphate biosynthesis III (Staphylococcus)
-
-
PWY-6907
thiamine diphosphate biosynthesis IV (eukaryotes)
-
-
PWY-6908
thiamine diphosphate salvage I
-
-
PWY-6896
thiamine diphosphate salvage II
-
-
PWY-6897
thiamine diphosphate salvage III
-
-
PWY-6898
thiamine diphosphate salvage IV (yeast)
-
-
PWY-7356
thiamine phosphate formation from pyrithiamine and oxythiamine (yeast)
-
-
PWY-7357
thiamine triphosphate metabolism
-
-
PWY-7369
thioredoxin pathway
-
-
THIOREDOX-PWY
thiosulfate disproportionation IV (rhodanese)
-
-
PWY-5350
threo-tetrahydrobiopterin biosynthesis
-
-
PWY-6983
thymine degradation
-
-
PWY-6430
thyroid hormone biosynthesis
thyroid hormone metabolism I (via deiodination)
-
-
PWY-6260
thyroid hormone metabolism II (via conjugation and/or degradation)
-
-
PWY-6261
toluene degradation II (aerobic) (via 4-methylcatechol)
-
-
TOLUENE-DEG-3-OH-PWY
toluene degradation to 2-hydroxypentadienoate (via toluene-cis-diol)
-
-
TOLUENE-DEG-DIOL-PWY
toluene degradation to 2-hydroxypentadienoate I (via o-cresol)
-
-
TOLUENE-DEG-2-OH-PWY
trans, trans-farnesyl diphosphate biosynthesis
-
-
PWY-5123
trans-3-hydroxy-L-proline degradation
-
-
PWY-7515
trans-caffeate degradation (aerobic)
-
-
PWY-8003
traumatin and (Z)-3-hexen-1-yl acetate biosynthesis
-
-
PWY-5410
trehalose biosynthesis IV
-
-
PWY-2622
trehalose biosynthesis V
-
-
PWY-2661
trehalose degradation I (low osmolarity)
-
-
TREDEGLOW-PWY
trehalose degradation II (cytosolic)
-
-
PWY0-1182
trehalose degradation IV
-
-
PWY-2722
trehalose degradation V
-
-
PWY-2723
trehalose degradation VI (periplasmic)
-
-
PWY0-1466
triacylglycerol degradation
-
-
LIPAS-PWY
tRNA charging
-
-
TRNA-CHARGING-PWY
tRNA methylation (yeast)
-
-
PWY-6829
tRNA processing
-
-
PWY0-1479
tRNA splicing I
-
-
PWY-6689
tRNA splicing II
-
-
PWY-7803
Tropane, piperidine and pyridine alkaloid biosynthesis
-
-
Tryptophan metabolism
-
-
tryptophan metabolism
-
-
tunicamycin biosynthesis
-
-
PWY-7821
type I lipoteichoic acid biosynthesis (S. aureus)
-
-
PWY-7817
type IV lipoteichoic acid biosynthesis (S. pneumoniae)
-
-
PWY-7818
Ubiquinone and other terpenoid-quinone biosynthesis
-
-
UDP-alpha-D-galactofuranose biosynthesis
-
-
PWY-7622
UDP-alpha-D-galactose biosynthesis
-
-
PWY-7344
UDP-alpha-D-glucose biosynthesis
-
-
PWY-7343
UDP-alpha-D-glucuronate biosynthesis (from myo-inositol)
-
-
PWY-4841
UDP-alpha-D-glucuronate biosynthesis (from UDP-glucose)
-
-
PWY-7346
UDP-alpha-D-xylose biosynthesis
-
-
PWY-4821
UDP-GlcNAc biosynthesis
-
-
UDP-N,N'-diacetylbacillosamine biosynthesis
-
-
PWY-7028
UDP-N-acetyl-alpha-D-mannosaminouronate biosynthesis
-
-
PWY-7335
UDP-N-acetyl-D-galactosamine biosynthesis I
-
-
PWY-5512
UDP-N-acetyl-D-galactosamine biosynthesis II
-
-
PWY-5514
UDP-N-acetyl-D-galactosamine biosynthesis III
-
-
PWY-8013
UDP-N-acetyl-D-glucosamine biosynthesis I
-
-
UDPNAGSYN-PWY
UDP-N-acetyl-D-glucosamine biosynthesis II
-
-
UDPNACETYLGALSYN-PWY
UDP-N-acetylmuramoyl-pentapeptide biosynthesis I (meso-diaminopimelate containing)
-
-
PWY-6387
UDP-N-acetylmuramoyl-pentapeptide biosynthesis II (lysine-containing)
-
-
PWY-6386
UDP-N-acetylmuramoyl-pentapeptide biosynthesis III (meso-diaminopimelate containing)
-
-
PWY-7953
UDP-yelosamine biosynthesis
-
-
PWY-7842
ultra-long-chain fatty acid biosynthesis
-
-
PWY-8041
UMP biosynthesis I
-
-
PWY-5686
UMP biosynthesis II
-
-
PWY-7790
UMP biosynthesis III
-
-
PWY-7791
uracil degradation I (reductive)
-
-
PWY-3982
urate conversion to allantoin I
-
-
PWY-5691
urate conversion to allantoin II
-
-
PWY-7394
urate conversion to allantoin III
-
-
PWY-7849
urea degradation II
-
-
PWY-5704
UTP and CTP de novo biosynthesis
-
-
PWY-7176
UTP and CTP dephosphorylation I
-
-
PWY-7185
UTP and CTP dephosphorylation II
-
-
PWY-7177
Valine, leucine and isoleucine biosynthesis
-
-
Valine, leucine and isoleucine degradation
-
-
valproate beta-oxidation
-
-
PWY-8182
vancomycin resistance I
-
-
PWY-6454
vancomycin resistance II
-
-
PWY-6455
vanillin and vanillate degradation I
-
-
PWY-7097
vanillin and vanillate degradation II
-
-
PWY-7098
vanillin biosynthesis I
-
-
PWY-5665
Various types of N-glycan biosynthesis
-
-
vernolate biosynthesis III
-
-
PWY-6917
very long chain fatty acid biosynthesis I
-
-
PWY-5080
very long chain fatty acid biosynthesis II
-
-
PWY-7036
viridicatumtoxin biosynthesis
-
-
PWY-7659
vitamin B1 metabolism
-
-
Vitamin B6 metabolism
-
-
vitamin B6 metabolism
-
-
vitamin D3 biosynthesis
-
-
PWY-6076
vitamin D3 metabolism
-
-
vitamin E biosynthesis (tocopherols)
-
-
PWY-1422
wax esters biosynthesis II
-
-
PWY-5885
wogonin metabolism
-
-
PWY-7213
xanthine and xanthosine salvage
-
-
SALVPURINE2-PWY
xanthohumol biosynthesis
-
-
PWY-5135
xanthommatin biosynthesis
-
-
PWY-8249
xylitol degradation I
-
-
LARABITOLUTIL-PWY
xyloglucan degradation II (exoglucanase)
-
-
PWY-6807
zymosterol biosynthesis
-
-
PWY-6074
adipate degradation
-
-
PWY-8354
bile acid biosynthesis, neutral pathway
-
-
PWY-6061
bile acid biosynthesis, neutral pathway
-
-
catecholamine biosynthesis
-
-
PWY66-301
catecholamine biosynthesis
-
-
cis-vaccenate biosynthesis
-
-
PWY-5973
cis-vaccenate biosynthesis
-
-
cyanate degradation
-
-
CYANCAT-PWY
dolichol and dolichyl phosphate biosynthesis
-
-
PWY-6129
dolichol and dolichyl phosphate biosynthesis
-
-
enterobactin biosynthesis
-
-
ENTBACSYN-PWY
enterobactin biosynthesis
-
-
folate polyglutamylation
-
-
PWY-2161
folate polyglutamylation
-
-
ketogluconate metabolism
-
-
KETOGLUCONMET-PWY
ketogluconate metabolism
-
-
methylaspartate cycle
-
-
PWY-6728
methylaspartate cycle
-
-
myo-inositol biosynthesis
-
-
PWY-2301
myo-inositol biosynthesis
-
-
octane oxidation
-
-
P221-PWY
thyroid hormone biosynthesis
-
-
PWY-6241
thyroid hormone biosynthesis
-
-
urea cycle
-
-
PWY-4984
vitamin K-epoxide cycle
-
-
PWY-7999
vitamin K-epoxide cycle
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
brenda
-
not rat
brenda
-
mineralization by PHOSPHO1 in medullary bone
brenda
-
digestive tract
brenda
allantoic fluid concentrates proteolytic enzymes assumed to participate in digestive processes: aminopeptidase Ey, dipeptidyl peptidase-4, meprin A, and 72 kDa type IV collagenase preproprotein
brenda
-
chicken B-cell system DT40 is used
brenda
-
-
brenda
-
chicken B-cell line DT40 is used
brenda
-
in vitro vasculogenesis model. Activities of both Ca2+-dependent and independent isoform PC-PLC and the level of reactive oxygen species are elevated during the endothelial differentiation of the blastodisc. Ca2+-independent PC-PLC undergoes an increase in 24 h, then decreases gradually with the cell differentiation, while Ca2+-dependent PC-PLC is almost not changed during the process
brenda
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
-
brenda
-
isozyme type III
brenda
-
brenda
-
brenda
-
from distal parts of the limb buds of 4-day-old Ross hybrid chicken embryos
brenda
-
brenda
-
-
brenda
-
embryo
brenda
low enzyme expression level
brenda
-
brenda
-
PDE5A1 and PDE5A3 show an increase from embryonic day 10 to embryonicday18 and from embryonic day 18 to 5-day post-hatching chick. PDE5A2 undergoes a marked increase (about 38fold) in the first period and remains nearly constant between embryonic day 18 and 5-day post-hatching chicken
brenda
-
brenda
-
brenda
-
-
brenda
-
brenda
-
-
brenda
-
ALK2, nontransforming ventricular, misexpression of LAK2 in endocardial cells
brenda
-
area pelludica, area opaca
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
embryo, high enzyme activity
brenda
tubular gland cells of the magnum
brenda
-
-
brenda
-
ciliary
brenda
-
brenda
the GATM gene displays biallelic expression in primordial germ cells
brenda
-
-
brenda
-
after beta-actin, cytosolic brain isoform of creatin kinase is the most abundant protein in hair bundle and capable of maintaining high aTP levels despite 1 mM/s ATP consumption by the plasma-membrane Ca2+-ATPase
brenda
-
-
brenda
-
-
brenda
-
brenda
-
-
brenda
-
brenda
-
-
brenda
-
-
brenda
-
high activity
brenda
-
mesenchymal cell
brenda
-
brenda
expression in T lymphocytes but not in B lymphocytes
brenda
-
parental and caspase-6-DT40 chicken lymphoma cells
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
somtes, extra- and intraembryonic lateral, and blood islands
brenda
-
brenda
-
brenda
-
primary cell culture
brenda
-
-
brenda
-
-
brenda
-
-
brenda
expression of chick EphA7 during segmentation of the central and peripheral nervous system EphA7 expression is restricted to prosomeres 1 and 2 in the diencephalon and all the rhombomeres in the hindbrain during segmentation stages. Later on, a superimposed pattern appears that correlates with the formation of several axonal tracts. In the somitic mesoderm, the expression correlates with segmentation and the guidance of both neural crest and motor axons through the sclerotomes
brenda
-
distribution of MMP9 in both emigrating and migrating neural crest cells, overview
brenda
-
-
brenda
-
-
brenda
-
brenda
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
brenda
-
cultured photoreceptor cells of embryonic retina
brenda
-
-
brenda
-
brenda
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
-
brenda
B5BSK4 AND B5BSD5
-
brenda
low expression level
brenda
-
-
brenda
-
Art7.1, but not Art7.2, is predominant on T-cells
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
-
brenda
-
-
brenda
-
-
brenda
-
brenda
-
-
brenda
-
fertilized eggs
brenda
-
brenda
-
highest activity observed
brenda
-
low activity
brenda
subcutaneous fat and abdominal fat, high expression level
brenda
-
brenda
higher expression levels in the liver, kidney, adrenal gland and ovary
brenda
-
-
brenda
-
embryo
brenda
-
embryonic and adult, smooth muscle, throughout development, exclusive expression of the splice-in myosin-targeting subunit isoform
brenda
-
smooth muscle
brenda
-
-
brenda
-
omega-amidase activity is about the same in cultured chick astrocytes and neurons
brenda
-
primary cultures of astrocytes
brenda
-
-
brenda
-
cells
brenda
-
erythrocyte
brenda
-
trace amounts
brenda
-
-
brenda
-
creatine kinase activity is much greater females than in males. Plasma creatine kinase activity may reflect the protein turnover, which is closely related to muscle growth rate
brenda
-
-
brenda
-
angiogenic
brenda
-
associated on the surface of
brenda
-
-
brenda
-
embryo
brenda
from 3 weeks old male chickens, from tibia, diaphyseal cortical and trabecular bone, expression pattern, PHOSPHO1 is specifically expressed at sites of mineralization in bone and cartilage
brenda
-
high levels in matrix vesicles from growth plate chondrocytes
brenda
-
leg
brenda
-
matrix vesicles
brenda
-
membranous bones of chick embryos
brenda
-
brenda
high level
brenda
highest enzyme expression level
brenda
predominantly
brenda
-
803, 988, 989, 995, 1179, 1712, 5364, 33352, 114156, 114159, 114160, 114192, 134923, 134945, 135380, 135381, 135404, 135685, 171965, 246781, 246800, 286091, 288890, 391541, 438244, 487126, 487277, 488193, 488495, 489215, 489221, 489305, 489312, 489336, 489404, 490440, 490578, 490579, 636879, 638392, 638776, 639653, 642371, 642374, 644201, 644202, 644205, 644207, 644359, 645316, 647259, 647260, 647264, 655198, 656601, 661528, 664725, 668120, 668684, 669164, 673175, 677529, 690427, 693713, 695206, 702387, 708981, 710096, 719334, 723168, 723559, 764890
brenda
-
7- to 12-day old embryonic chicken brain
brenda
-
8% activity compared to epiphyseal cartilage
brenda
-
almost no expression and activity
brenda
-
brain, cerebellum show about 6fold-higher activity than cerebrum. Expression detected in in Bergmann-glia cells of the cerebellum and in astrocytes
brenda
Cek5 variant is expressed in the brain, but not in other tissues of the 10-day chick embryo
brenda
-
cerebellum excluded
brenda
-
cerebral omega-amidase activity is relatively high at embryonic day 5 but lower between days 5 and 17, at embryonic day 23 activity rises to a maximum
brenda
-
common-type enzyme
brenda
-
embryo
brenda
-
embryo brain
brenda
-
embryonic
brenda
-
embryonic and adult brain
brenda
-
embryonic and myelinated brain, the specific activity increases with myelination
brenda
-
embryonic, the aryl acylamidase is associated with acetylcholinesterase in chicken embryonic brain
brenda
-
enolase I (alpha,alpha-enolase), enolase II (alpha,gamma-enolase), enolase III (gamma,gamma-enolase)
brenda
-
enzyme activity on acetylcholinesterase is high during early chicken brain development, developmental profiles of aryl amidase activities along with acetylcholinesterase and butyrylcholinesterase activities from embryonic days E3 to hatching, E21, in Triton-X-100-solubilized homogenates from chicken embryonic brains, overview
brenda
expression of Cek5 in the brain gradually diminishes during embryonic development
brenda
faintly expressed
brenda
-
forebrain
brenda
-
glutamine synthetase transcripts of liver and brain cells are identical, no difference in the amino acid sequence of the protein. The N-terminus of glutamine synthetase, which constitutes a weak mitochondrial targeting signal, is sufficient to direct a chimeric protein to the mitochondria in hepatocytes and to the cytoplasm in astrocytes
brenda
in the tuberomammillary nucleus of the posterior hypothalamus
brenda
-
isozyme type III
brenda
-
low activity
brenda
-
low level of expression, low acitivity
brenda
-
neonatal
brenda
of the embryo
brenda
-
regional distribution
brenda
-
strong expression of PFK-L
brenda
-
synthases I, II and III
brenda
-
the brain alpha,gamma and gamma,gamma forms are not detectable in the early embryonic stage and increase gradually during the development of the brain, whereas the alpha,alpha form exists at an almost constant level during development
brenda
-
two enzyme isoforms in chicken, just one isoform in bullfrog
brenda
-
very low level
brenda
-
weak expression
brenda
-
activity of adenosine monophosphate deaminase is significantly higher in chicken of the fast-growing type than in the slow-growing French "Label Rouge" type, and in heavy line typ
brenda
-
low enzyme activity
brenda
-
Art7.1, but not Art7.2, is predominant on the surface of B-cells from the bursa of Fabricius as a glycosylphosphatidylinositol-anchored form
brenda
high enzyme expression level
brenda
very low level
brenda
-
embryo
brenda
from 17 days old embryonic chickens, PHOSPHO1 gene expression
brenda
-
brenda
-
from embryos, in myofibril precursors and sarcomeric Z-lines, co-localization with myosin IIB
brenda
-
-
brenda
-
cartilage and cartilagenous bone
brenda
-
embryo
brenda
-
embryo cartilage
brenda
-
embryonal
brenda
-
embryonic
2416, 439149, 489285, 636777, 637610, 637611, 637612, 637613, 637622, 645747, 645911, 658463, 658761, 659112, 733208
brenda
-
epiphyseal
brenda
-
epiphyses from embryonic femurs and tibiae
brenda
from 3 weeks old male chickens, from tibia, growth plate cartilage, expression pattern, PHOSPHO1 is specifically expressed at sites of mineralization in bone and cartilage
brenda
-
from limb
brenda
-
hypertrophic and nonhypertrophic
brenda
-
-
brenda
-
carbonic anhydrase appears within 2 days of birth
brenda
high enzyme expression level
brenda
-
microbiol azoreductase activity
brenda
-
-
brenda
-
chondrocytes
brenda
-
DT40 cell from chicken, that expresses active PIPkin IIbetA tagged at the C-terminus of Hef, a protein component of the Fanconi anemia-related tumor-suppressor complex.
brenda
-
Enzymes expressed in Escherichia coli
brenda
-
of hypertrophic and nonhypertrophic cells and chondrocytes
brenda
-
brenda
-
brain, cerebellum show about 6fold-higher activity than cerebrum
brenda
-
isozyme type III
brenda
low expression level
brenda
-
Purkinje cells
brenda
-
brenda
-
brain, cerebellum show about 6fold-higher activity than cerebrum
brenda
-
-
brenda
-
cell culture
brenda
-
cultured embryo vertebral chondrocytes
brenda
-
embryo
brenda
-
embryo chondrocytes release enzyme into the cell culture medium
brenda
-
extracellular, secretion to the medium
brenda
from growth plates of proximal tibiotarsi, 3X11A expression at high levels in differentiating growth plate chondrocytes, 3X11A expression is upregulated 5fold during chondrocyte terminal differentiation and its expression is approximately 100fold higher in hypertrophic chondrocytes than in non-chondrogenic tissues
brenda
-
hypertrophic and nonhypertrophic
brenda
-
in tissue culture, enzyme activity increases up to mid-log phase and decreases rapidly as the growth rate declines
brenda
-
small GTPase protein Rac-1 is activated with maturation and regulates cell morphology and function in chondrocytes
brenda
-
-
brenda
-
MMP-13 is the only enzyme whose induction and expression coincides with the onset of angiogenesis and blood vessel formation. MMP-13-positive cells appear shortly after angiogenic stimulation and then accumulate in the collagen onplant tissue. Morphologically, the chMMP-13-containing cells appear as hematopoietic cells of monocyte/macrophage lineage
brenda
-
brenda
-
high level of expression and activity
brenda
-
696414, 699048, 700151, 717301, 717672, 718309, 728876, 728985, 728996, 729117, 729212, 729398, 729841, 729871, 730842, 752907
brenda
-
purified
brenda
-
cultured tendon fibroblasts
brenda
-
from Rous-sarcoma virus-transformed chicken embryo fibroblasts
brenda
-
of 17-day-old embryo tendons
brenda
-
-
brenda
high enzyme expression level
brenda
high expression level
brenda
-
brenda
-
albumen
brenda
-
egg white
brenda
-
egg yolk
brenda
-
expressed in the chicken egg citelline membrane: using high-throughput, high-end LC-mass spectroscopy 137 proteins are identified. Specific components of the vitelline membrane not identified previously in other egg compartments include eight zona pellucida proteins, oviductin protease, and two ATPases
brenda
-
fertilized
brenda
-
35016, 171035, 171038, 171039, 171057, 171062, 171069, 171089, 171092, 171094, 171099, 171103, 171105, 171106, 171107, 171111, 657645, 657948, 657990, 659861, 663498, 663508, 663510, 663529, 664786, 665003, 665757, 665993, 666541, 666704, 677858, 678407, 678484, 678844, 679189, 679544, 680207, 680255, 680380, 680541, 680954, 681060, 681598, 681709, 682603, 683018, 695524, 696021, 698409, 699054, 699629, 699858, 700151, 707414, 707830, 708358, 708362, 708795, 708875, 709764, 710026, 710491, 717036, 717301, 717672, 718309, 718362, 728876, 728985, 728996, 729117, 729212, 729398, 729841, 729871, 730842, 749500, 750591, 750595, 750836, 751931, 752907
brenda
-
fertilized eggs
brenda
-
lysoPLD secreted in several animal body fluids. Hen egg white originates mainly from the hen oviduct fluid, which contains various bioactive molecules acting on the oviduct, ova, and sperm
brenda
-
very low activity
brenda
-
-
brenda
-
Cu/Zn-superoxide dismutase isozymes
brenda
-
intraoocytic
brenda
-
plasma
brenda
-
plasma, isozyme pattern, overview
brenda
-
133, 1923, 3076, 3995, 134392, 134445, 208431, 288890, 288997, 289009, 289010, 289020, 349014, 439129, 439148, 439149, 439151, 439152, 439153, 439154, 439156, 439158, 439159, 439160, 439162, 439179, 439183, 439184, 439185, 439186, 439189, 439190, 439191, 439192, 439193, 439194, 439195, 439196, 439197, 439199, 439200, 439204, 439205, 439206, 439207, 439209, 439210, 439212, 439215, 439224, 439225, 439228, 439230, 439235, 439237, 439242, 485359, 485363, 485372, 485384, 485387, 485964, 486514, 486818, 486832, 486836, 489404, 489437, 490280, 490491, 636781, 636782, 637611, 637612, 637613, 637622, 638081, 638321, 640055, 640074, 640810, 640811, 640812, 641138, 641999, 643416, 643594, 643756, 644807, 644809, 645747, 645911, 650782, 655187, 665517, 665792, 667197, 668857, 670800, 671660, 678473, 680636, 690427, 692181, 692668, 698909, 705249, 713952, 733208, 734597, 736432, 749803, 755594
brenda
-
14-15 days old
brenda
-
active in apoptotic cells
brenda
at embryonic day 2, Cek9 immunoreactivity is concentrated in the eye, the brain, the posterior region of the neural tube, and the most recently formed somites. Later in development, Cek9 expression is widespread but particularly prominent in neural tissues
brenda
-
both the chicken heparanase mRNA and protein are expressed 12 h post fertilization, in cells migrating from the epiblast and forming the hypoblast layer. Later on 72 h, the enzyme is preferentially expressed in cells of the developing vascular and nervous systems
brenda
-
brain
brenda
-
brain, liver and heart
brenda
-
cartilage
brenda
Cek5 variant is expressed in the brain, but not in other tissues of the 10-day chick embryo
brenda
-
cell culture
brenda
-
cerebral omega-amidase activity is relatively high at embryonic day 5 but lower between days 5 and 17, at embryonic day 23 activity rises to a maximum
brenda
-
embryo brain
brenda
-
embryo cartilage
brenda
-
embryo liver
brenda
embryonic fibroblasts
brenda
expression at low level
brenda
expression of Cek5 in the brain gradually diminishes during embryonic development
brenda
fibroblasts
brenda
from chicken eggs
brenda
greatest levels of expression occurring in the brain
brenda
-
H+/K+-ATPase and Kir4.1 are expressed in the primitive streak
brenda
-
hepatocytes and fibroblasts
brenda
-
homogenates and cartilage
brenda
-
in the lumen of the cranial and cervical neural tubes
brenda
-
initially expressed at gastrulation stages, later during dorso-ventral patterning of the neural tube in neural crest and ventrally in the caudal notochord and floor plate, and during patterning of the somites
brenda
-
leg
brenda
localized to focal adhesion
brenda
-
maximal activity in 19-20 day-old embryos
brenda
-
muscle
brenda
neural folds
brenda
-
occurs with beginning of gastrulation, cardiovascular compartment and hematopoietic compartment, i.e. yolk sac and aorta-gonad-mesonephros region
brenda
-
PHOSPHO1 expression occurs prior to E6.5 and is initially restricted to the bone collar within the mid-shaft of the diaphysis of long bones. By E11.5, expression is observed over the entire length of the diaphysis
brenda
-
retina
brenda
-
single-nucleotide polymorphisms is an adaptation to the external anoxic environment
brenda
-
tendon cell, cartilage, skin, spleen
brenda
-
tendons and sterna
brenda
-
the complete ADAM12 is stably expressed throughout chicken embryonic development, while the truncated isoform is only regionally detectable in the lung and brain. ADAM12 is expressed exclusively in tissues and organs derived from the neural tube, the neural crest or the mesoderm
brenda
the GATM gene displays biallelic expression in somatic embryonic and extraembryonic tissues
brenda
the SPS1 mRNA level of chicken embryo neurons alters with the different Se concentration
brenda
-
ventricular cells
brenda
-
yolk-sac
brenda
-
cartilage
brenda
-
cartilage, embryo
brenda
-
chondrocytes in epiphyses and bordering vascular canals express lower levels of total (inactive plus active) and active p38 MAPK
brenda
-
embryonic
brenda
-
highest activity
brenda
-
-
brenda
-
lens
brenda
-
of rumen
brenda
-
of the intestine, brush border cells
brenda
-
994, 3791, 3811, 3824, 3826, 4418, 4419, 4421, 4426, 4434, 33562, 34938, 34950, 37446, 114220, 209675, 210708, 246781, 246800, 286014, 390944, 390950, 390958, 390972, 390973, 485605, 486820, 486850, 489654, 638115, 638121, 641138, 641999, 642786, 647143, 654965, 654966, 654975, 662346, 678018, 678123, 694894, 695960, 698034, 701981, 702215, 708981, 712835, 724548
brenda
-
carbonic anhydrase B and C
brenda
-
common type enzyme
brenda
-
developmental expression profile of CA-II in erythrocytes of male and female chicken, age-related changes of CA-II levels in erythrocytes, overview
brenda
-
embryo
brenda
-
embryonic
brenda
-
heparinized blood
brenda
-
isozyme Cu/Zn SOD
brenda
-
low activity
brenda
-
nucleated
brenda
-
very low activity
brenda
-
-
brenda
high enzyme expression level
brenda
-
mainly in the smooth muscle and in the mucosa
brenda
-
brenda
in wild-type embryos, RALDH-3 is expressed within the developing eye vesicle in the ventral third of the retina
brenda
in wild-type embryos, the distribution of Raldh-1 is limited to the dorsal third of the eye
brenda
retina
brenda
-
uvea
brenda
-
brenda
-
adipofibroblast, embryonic cell culture, up to 10fold increase of activity in presence of chicken serum, further increase in presence of embryonic chicken serum
brenda
-
embryo
brenda
-
embryo, 7 days old
brenda
-
embryonic, large myosin phosphatase target subunit MYPT
brenda
from embryo
brenda
-
normal and Rous sarcoma transformed
brenda
-
prepared from embryonal chicken hearts
brenda
-
134605, 134651, 640620, 640624, 640635, 640639, 640640, 640645, 640648, 640649, 640650, 640651, 640652, 640653, 640655, 640686, 640687, 643867, 646352, 646354, 646357, 646361, 646368, 646371, 655930, 689744, 708823, 733680, 740060, 740266
brenda
faintly expressed
brenda
high enzyme expression level
brenda
-
low activity
brenda
low expression level
brenda
-
low level
brenda
-
muscle
brenda
-
rat pancreatic and turkey gizzard enzyme are immunologically related
brenda
-
smooth muscle
brenda
-
-
246976, 246979, 246984, 246985, 246989, 492101, 492132, 646349, 646351, 646355, 718546
brenda
-
embryonic and adult, early during development, expression of the splice-in myosin-targeting subunit isoform, then shift from the splice-in to the splice-out isoform, exclusive expression of the splice-out isoform in adult chicken
brenda
-
brenda
high enzyme expression level
brenda
low expression level
brenda
-
brenda
-
low level of expression
brenda
-
weak expression
brenda
peripheral blood granulocyte
brenda
-
peripheral polymorphonuclear
brenda
-
brenda
-
pre-ovulatory follicle F1
brenda
-
preovulatory follicular
brenda
procaspase-3 level is elevated 2fold to 5fold in preovulatory, compared to prehierarchal follicle granulosa cells
brenda
-
chicken HD11 macrophage cell
brenda
-
macrophage cell line
brenda
E1C0W6, F1NP39, P00356, P11009, Q0KKP4, Q0KKP5, Q2QB49, Q2QB50, Q49L19, Q49L21, Q7T3T4, Q98943, S6BNL5
-
803, 988, 989, 995, 5364, 134445, 134933, 134945, 171965, 246781, 246800, 285912, 285918, 286091, 286464, 286471, 389477, 390820, 391541, 396418, 438244, 439242, 489336, 639824, 639865, 639875, 642371, 642372, 642373, 642375, 642376, 642377, 642385, 645316, 656601, 657211, 657869, 661528, 664548, 671041, 673147, 674600, 702387, 708981, 723168, 733680, 742889
brenda
-
ALK2 and ALK5, atrioventricular cushion of developing heart
brenda
-
Art7.1 and Art7.2
brenda
-
common-type enzyme
brenda
-
embryo
brenda
expression at low level
brenda
-
expression only in the early developmental stages
brenda
-
Go-alpha subunit
brenda
-
low activity
brenda
-
low enzyme activity
brenda
low enzyme expression level
brenda
-
low level of expression, low activity
brenda
-
trace amounts
brenda
-
very low level
brenda
-
weak expression
brenda
-
brenda
-
culture
brenda
-
embryonal, cultured
brenda
-
embryonic
brenda
-
from embryo
brenda
DU249 chicken hepatoma cells, contain p60 but no measurable formiminotransferase activity, may be due to the low expression of p60
brenda
isoform of the formiminotransferase cyclodeaminase enzyme complex
brenda
high expression level
brenda
highly expressed in the hypothalamic infundibulum, the cells containing HDC mRNA are localized in the medial mammillary nucleus of the hypothalamic infundibulum
brenda
-
-
brenda
high enzyme expression level
brenda
-
low activity
brenda
-
286091, 488193, 488495, 642371, 647310, 656601, 665882, 668684, 677550, 684105, 695120, 703310
brenda
-
activity changes considerably under different dietary situations
brenda
-
carbonic anhydrase B and C
brenda
-
epithelium
brenda
faintly expressed
brenda
-
high enzyme activity
brenda
-
high expression
brenda
-
high level of expression and activity
brenda
highest expression in duodenum, mRNA level in ileum is markedly low
brenda
-
in the serosa of and in the boundary between the smooth muscle and submucosa
brenda
-
intestinal brush border membrane vesicles isolated from 3- or 6-week-old broiler chickens. Concanavalin A has no effect on enzyme activity. Activity is lower in 6-week-old than in 3-week-old broilers
brenda
-
microbiol azoreductase activity in large intestine
brenda
-
mucosa
brenda
-
trace amounts
brenda
-
brenda
high enzyme expression level
brenda
-
803, 1712, 3414, 5364, 81109, 94602, 134923, 134945, 137135, 210780, 246800, 285537, 285912, 285918, 286091, 286093, 288569, 389677, 389697, 391541, 394352, 438244, 439200, 439228, 439242, 440101, 440104, 440105, 440108, 440109, 440110, 440111, 440113, 440121, 440123, 485894, 485919, 485964, 485967, 486248, 487126, 488495, 488746, 636311, 636313, 636315, 636319, 641949, 642786, 643759, 643774, 643775, 645546, 656601, 657869, 668684, 673147, 677529, 679333, 692954, 694139, 702387, 703310, 705379, 708981, 715627, 723168, 728646, 728887, 737153, 745408
brenda
-
about the same activity as in muscle
brenda
-
brush-border membrane of proximal tubule cells
brenda
-
common-type enzyme
brenda
-
cortex and medula
brenda
-
distribution
brenda
-
embryo, mesonephros and metanephros
brenda
expression at low level
brenda
expression is associated with the tubular epithelial cells and with the transitional epithelium, and the inner longotudinal and outer circular muscle layers of the ureter
brenda
faintly expressed
brenda
-
high enzyme activity
brenda
-
high expression
brenda
high level of enzyme mRNA
brenda
-
high level of expression and activity
brenda
-
higher activity than in liver
brenda
higher expression levels in the liver, kidney, adrenal gland and ovary
brenda
-
highest activity found in kidney. Expression in proximal tubule cells
brenda
-
in the tubules
brenda
low enzyme expression level
brenda
low expression level
brenda
maximal expression in a thin layer of hepatocates bordering the blood veins
brenda
-
most abundant
brenda
-
much lower activity than in muscle
brenda
-
not rat
brenda
only marginal activity
brenda
-
proximal tubule
brenda
-
richest source
brenda
-
-
brenda
-
embryo
brenda
-
-
brenda
-
embryo, lowest enzyme activity
brenda
-
fiber cells, epithelium
brenda
A0A1D5NU03, E1C0W6, E1C5G9, E1C878, F1N8Y3, F1NP39, F1NQP1, F1P2T2, I7C3V5, P07850, P15505, P15505 and P11183 and P28337, P21642, Q0KKP4, Q0KKP5, Q45QT1, Q5ILH2, Q9I993, Q9I9K9, Q9YH58, S6BNL5, U5LV87, U5LXR4
-
338, 340, 341, 995, 1261, 1263, 1265, 1309, 1310, 1312, 1389, 1409, 1412, 1413, 1506, 1614, 1663, 1665, 1666, 1667, 1712, 1769, 1773, 1776, 1781, 1785, 1786, 1787, 1789, 1790, 1792, 1795, 1797, 2937, 2940, 2944, 2960, 3962, 4345, 4350, 4353, 4359, 4367, 4370, 4372, 4374, 4378, 4379, 4380, 4384, 5181, 5364, 5584, 5594, 5744, 5758, 5776, 5997, 33352, 34325, 34992, 37055, 37498, 80975, 81015, 81050, 94265, 94472, 94936, 94954, 95032, 95048, 95283, 134445, 134481, 134796, 134923, 134935, 134941, 134945, 137135, 170777, 170800, 171011, 171012, 171165, 171965, 172098, 172116, 172158, 172166, 208670, 208949, 209057, 209247, 209254, 209256, 209546, 209661, 209721, 209731, 210241, 210704, 210708, 210780, 246781, 246800, 285599, 285701, 285717, 285720, 285971, 285974, 286088, 286091, 286092, 286093, 286615, 286724, 287177, 287526, 287541, 287543, 287544, 287884, 347762, 347927, 389555, 389684, 389697, 390763, 391343, 391541, 391801, 391978, 391981, 391986, 391988, 392208, 392222, 392224, 392261, 392262, 392274, 392335, 393008, 393796, 394307, 394352, 395370, 395386, 395388, 395451, 396199, 396418, 396644, 437646, 437653, 437657, 437658, 438230, 438244, 438245, 438368, 439148, 439149, 439186, 439200, 439242, 441183, 441231, 441586, 485693, 485712, 485713, 485714, 485716, 485721, 485724, 485725, 485727, 485734, 485735, 485738, 485742, 485964, 485967, 485978, 486483, 486514, 486534, 486549, 486820, 486850, 487112, 487129, 487130, 487574, 487575, 487577, 487579, 487580, 487593, 487595, 487669, 487671, 488093, 488095, 488096, 488098, 488099, 488100, 488101, 488102, 488103, 488105, 488106, 488107, 488110, 488111, 488113, 488114, 488115, 488116, 488122, 488192, 488204, 488495, 488513, 488746, 489336, 489439, 489654, 489657, 489663, 489666, 587068, 638110, 638223, 638228, 638237, 638321, 638697, 639412, 639856, 639865, 640055, 640074, 640307, 640339, 640421, 640487, 641181, 641202, 641287, 641292, 641445, 642034, 642371, 642661, 642710, 642786, 643693, 643758, 643759, 644346, 644572, 644576, 644579, 644582, 644606, 644613, 644647, 644794, 645316, 645383, 645384, 645546, 645771, 645772, 646160, 646471, 647143, 647290, 647291, 647912, 649461, 649936, 649995, 650021, 653873, 655265, 655272, 656601, 656707, 657570, 658953, 658954, 661027, 661369, 662527, 663193, 664193, 667608, 668325, 668684, 670650, 671582, 672604, 673058, 673147, 673175, 676756, 676758, 677529, 678205, 684795, 688044, 689727, 694023, 696580, 696908, 698096, 700919, 702387, 703310, 704831, 711242, 712157, 720118, 724796, 724797, 724831, 726545, 727092, 728647, 731463, 733680, 735850, 737153, 737294, 737579, 744613, 745408, 752316, 752793, 756511, 757909, 758528, 758693, 758718, 759115, 759438, 759446, 759450, 759451, 760442, 762018
brenda
-
about 60% of activity of adipose tissue
brenda
-
activity in the corn-based diet group is significantly higher than that in the rice-based diet group
brenda
-
activity is increased in liver during starvation
brenda
-
almost no expression and activity
brenda
-
bile canaliculi
brenda
-
common-type enzyme
brenda
-
Cu,Zn-SOD
brenda
embryo
brenda
-
embryo liver
brenda
-
embryonic
brenda
-
embryonic and adult
brenda
-
embryonic liver
brenda
expression of chicken ST3Gal3 is generally low in all the organs tested, although a certain level of expression is observed with ST3Gal3 in the liver
brenda
expressionis associated with tubular epithelial cells and with the transitional epithelium, and the inner longitudinal and outer circular muscle layers of the ureter
brenda
faintly expressed
brenda
-
fetal
brenda
-
foetal
brenda
from chicken eggs
brenda
-
glutamine synthetase transcripts of liver and brain cells are identical, no difference in the amino acid sequence of the protein. The N-terminus of glutamine synthetase, which constitutes a weak mitochondrial targeting signal, is sufficient to direct a chimeric protein to the mitochondria in hepatocytes and to the cytoplasm in astrocytes
brenda
-
high enzyme activity
brenda
-
high expression
brenda
high level
brenda
-
high level of expression and activity
brenda
higher expression levels in the liver, kidney, adrenal gland and ovary. mRNA levels in the liver rapidly increase after hatching, with a maximum on d 5 posthatching, after which they gradually decreased to adult levels
brenda
highest expression
brenda
-
isoenzyme L-2-hydroxyacid oxidase A
brenda
isoforms of the formiminotransferase cyclodeaminase enzyme complex
brenda
-
isozyme type III
brenda
-
laying hens
brenda
-
liver enzyme is active
brenda
-
low activity
brenda
low enzyme expression level
brenda
-
lower activity than in kidney
brenda
maximum protein expression is shown in a thin layer of hepatocytes bordering the blood veins
brenda
-
moderate enzyme activity
brenda
-
mRNA detected at very low level
brenda
-
no activity detected
brenda
-
not rat
brenda
only trace amounts of AOX1 activity
brenda
-
preneoplastic hepatic nodules
brenda
-
same activity than in muscle
brenda
the liver-type enzyme expression is constantly high in mature, 2-year-old male chicken compared to immature, 5-weak-old chickens, overview
brenda
-
type I and II
brenda
-
XOR activity reduced by allopurinol treatment. Birds fed with inosine and allopurinol show lower total XOR activity in liver but no effect in kidney
brenda
A8WEN5, E1C0W6, E1C878, F1NGY0, F1NP39, I6WCK5, I7C3V5, P53666, Q02977, Q05876, Q0KKP4, Q0KKP5, Q11200, Q7T3T4, Q92177, Q9DGD1, S6BNL5, U5LV87, U5LXR4
-
1712, 396418, 438244, 439200, 439242, 489336, 490542, 492028, 638110, 638240, 644015, 656601, 673147, 673175, 679333, 694139, 702387, 719334, 723168, 733680, 745411, 757909, 762408
brenda
-
Art7.1 and Art7.2
brenda
-
embryo
brenda
high enzyme expression level
brenda
-
low enzyme activity
brenda
predominantly
brenda
-
trace amounts
brenda
-
brenda
-
peritoneal, alveolar
brenda
E1C0W6, F1N9S8, F1NP39, P11799, P13538 and P02609 and P02604, Q0KKP4, Q0KKP5, Q49L19, Q49L21, Q7T3T4, Q92178, Q9I8D3, S6BNL5
-
988, 995, 998, 2568, 3258, 4921, 36452, 36720, 36920, 36921, 36943, 81110, 114164, 137040, 170741, 170777, 246781, 286134, 286135, 286136, 286464, 286471, 287967, 485238, 491241, 640686, 641287, 642265, 643867, 644015, 657869, 664643, 664644, 664652, 673147, 723168, 727027, 733680, 734309, 735033, 755220
brenda
-
activity in breast muscle is low when compared to leg muscle, starvation causes no change in enzyme activity
brenda
-
and muscular layer of rumen
brenda
breast
brenda
breast muscle
brenda
-
carbonic anhydrase A
brenda
-
carnosine synthetase shows a 50fold increase in activity between 2 and 15 days, with some evidence for decline in activity subsequent to 21 days
brenda
-
developing muscles of the trunk
brenda
-
embryonic
brenda
in the skeletal muscle of the thigh a sharp decrease in Cek5 expression is detected at the time of terminal muscle differentiation
brenda
-
leg, embryo
brenda
-
low activity
brenda
-
low level
brenda
-
muscle-type and common-type enzyme
brenda
-
pectoral
brenda
pectoral muscle
brenda
-
pectoralis
brenda
-
pectoralis major
brenda
-
pectoralis muscle
brenda
-
skeletal
brenda
-
skeletal muscle
brenda
smooth muscle
brenda
-
sternal
brenda
-
striated, a distinct MLCK isozyme
brenda
-
thigh and leg
brenda
-
trace amounts in breast muscle
brenda
-
-
brenda
-
4fold increase in expression in vagal versus sacral neural crest cells
brenda
JmjD2A transcripts are observed in the neural plate, neural plate border, and non-neural ectoderm, highest expression of JmjD2A at stage 5, decreasing from stage 8 onward
brenda
-
-
brenda
posterior region of neural tube
brenda
-
brenda
-
DRG neurons
brenda
histaminergic
brenda
-
omega-amidase activity is about the same in cultured chick astrocytes and neurons
brenda
-
primary cultured chicken embryos neurons
brenda
-
primary cultures of neurons
brenda
-
brenda
gene MMP9 is significantly upregulated in 23-wk-old (laying phase) chicken ovaries compared with 6-wk-old ovaries (prepubertal phase). In reproductively active chicken ovary, the enzyme expression level increases during follicular maturation. Enzyme MMP9 mRNA expression continues to rise in postovulatory follicle 1 and postovulatory follicle 2 after ovulation
brenda
higher expression levels in the liver, kidney, adrenal gland and ovary
brenda
level of caspase-3 does not change significantly in theca tissue during follicle development. Procaspase-3 level is elevated 2-fold to 5-fold in preovulatory, compared to prehierarchal follicle granulosa cells
brenda
-
low level of expression and activity
brenda
-
29815, 29819, 134465, 134466, 134637, 135552, 135963, 136048, 170960, 171688, 171705, 171720, 209065, 393661, 488370, 488494, 488495, 488500, 488503, 488513, 637245, 637306, 637622, 637988, 638213, 638223, 638228, 638237, 638240, 638241, 638242, 645924, 646606, 655914, 723168, 745411
brenda
-
distribution in magnum
brenda
glandular and luminal epithelia of the oviducts
brenda
-
high level of expression and activity
brenda
infundibulum, magnum, isthmus, and shell gland. Developmental changes, overview
brenda
magnum
brenda
-
magnum of oviduct, isthmus region
brenda
-
magnum region
brenda
-
predominantly in tubular glands and isthmus
brenda
-
secretory tissue
brenda
the expression level of ST3Gal6 in the magnum of the oviduct is almost a half that in the liver
brenda
-
trace amounts
brenda
-
tubular gland
brenda
-
1712, 95438, 134923, 134945, 137135, 171863, 171864, 171965, 396418, 485964, 485967, 485978, 643775, 647301, 647311, 653044, 656601, 677808, 683578, 703310, 706471, 708480
brenda
-
glucokinase gene and protein detected
brenda
-
trace amounts detected
brenda
-
brenda
low expression level
brenda
-
brenda
exposure of dark-adapted animals to near ultraviolet light significantly decreases melatonin content and the activity of serotonin N-acetyltransferase
brenda
expression of retinal GRK1
brenda
-
not surrounding areas
brenda
young and adult
brenda
-
-
brenda
high enzyme expression level
brenda
-
114196, 135380, 135381, 170654, 441480, 441483, 639423, 639426, 639514, 639515, 642371, 644328, 672075, 673102, 692668, 703323, 704084, 709690, 716114, 729213, 733680, 763516, 764890
brenda
-
AANAT activity is low during the daytime, increases rapidly early in the night and beginsto decline in anticipation of dawn
brenda
cone-dominant retina
brenda
-
cultured photoreceptor cells
brenda
-
cultured photoreceptor cells of embryonic retina
brenda
-
embryonic retina
brenda
-
embryonic retinal cell culture, developmental expression analysis of Cdk5-p35, Cdk5-p35 localize in the stable region of turning growth cones in developing retina
brenda
-
from embryo
brenda
in rod and cone photoreceptors
brenda
-
in the nuclear layer and pigment layer
brenda
-
is activated during development
brenda
-
photic regulation of arylalkylamine N-acetyltransferase binding to 14-3-3 proteins in retinal photoreceptor cells
brenda
the glycogen phosphorylase isoform BB (brain), but not the glycogen phosphorylase MM isoform (muscle) is expressed in the chicken retina in neuronal and glial cells. Glycogen phosphorylase is expressed in various layers of the retina some of which, e.g., the photoreceptor inner segments, are known to be sites of high energy consumption. This suggests important roles of glycogen phosphorylase BB, and therefore glycogen, in early differentiation, spontaneous wave generation and in formation and stabilization of synapses
brenda
-
-
brenda
-
membrane
brenda
-
-
brenda
-
calpain 12 appears to be involved in the regulation of flagellar movement, but not in that of the acrosome reaction
brenda
-
-
brenda
-
in hepatitis serum 4fold more active than in normal
brenda
-
492101, 492134, 492143, 638126, 640177, 640634, 640647, 649032, 657869, 684910, 702315, 708981, 723168, 756164
brenda
-
about 10% of activity of adipose tissue
brenda
-
beta,beta-enolase, complete switching from alpha,alpha enolase to beta,beta enolase during the period around hatching
brenda
-
breast, pectoralis major
brenda
-
contains a single enzyme form
brenda
-
fast muscle
brenda
-
high activity in breast muscle, low activity in leg muscle
brenda
-
low activity
brenda
lowest enzyme expression level
brenda
-
pectoralis
brenda
-
pectoralis muscle
brenda
-
red and white
brenda
-
strong expression of PFK-L. Two types of phosphofructokinase-1 (PFK-L and PFK-M) differentially regulate the glycolytic pathway in insulin-stimulated chicken skeletal muscle
brenda
-
two types of phosphofructokinase-1 (PFK-L and PFK-M) differentially regulate the glycolytic pathway in insulin-stimulated chicken skeletal muscle
brenda
-
brenda
-
embryo
brenda
high enzyme expression level
brenda
-
brenda
-
epithelium
brenda
-
high level of expression and activity
brenda
-
640624, 640634, 640635, 640645, 640647, 640648, 640649, 640652, 640653, 640655, 666435, 687732, 740060, 740266
brenda
-
from gizzard
brenda
-
uterus, trachea, aorta, ileum, gizzard
brenda
-
brenda
brachial and lumbar segments which innervate limb muscles
brenda
-
DDAH-1 mRNA expression is especially strong in the ventral horn and dorsal root ganglion, and also localized in cervical, thoracic and lumbar spinal cord and sympathetic ganglion
brenda
low enzyme expression level
brenda
-
-
brenda
-
the glutathione-independent PGD synthase is accumulated
brenda
E1C878, F1NGY0, I6WCK5, I7C3V5, P42683, Q02977, Q05876, Q0KKP4, Q0KKP5, Q11200, Q6R3Q5, Q7T3T4, Q9DGD1, U5LV87, U5LXR4
-
1712, 171965, 246800, 285912, 396418, 438244, 490440, 490542, 638110, 638123, 638240, 656601, 673147, 723168, 738726, 745411, 757909
brenda
-
common-type enzyme
brenda
-
embryo
brenda
expression at low level
brenda
faintly expressed
brenda
high enzyme expression level
brenda
high level
brenda
-
low level
brenda
predominantly
brenda
-
-
brenda
-
embryo, high enzyme activity
brenda
-
embryonic
brenda
-
brenda
-
in the serosa, mucosa and smooth muscle
brenda
-
-
brenda
-
embryo
brenda
-
embryo, highest activity
brenda
-
embryonal
brenda
-
metatarsal tendons obtained from E13 chick embryos
brenda
-
brenda
-
almost no expression and activity
brenda
expression levels of the testis-specific exon-1-containing gene are highly increased in mature, 2-year-old male chicken compared to immature, 5-weak-old chickens, overview
brenda
high enzyme expression level
brenda
-
low level
brenda
-
-
brenda
-
carboxypeptidase E is expressed in chicken thymus of both young (8-day-old) and older (17-week-old) chickens and in broilers and laying hens
brenda
high enzyme expression level
brenda
very low level
brenda
-
-
brenda
-
embryo
brenda
-
embryo, high enzyme activity
brenda
-
-
brenda
membranes, of chicken eggs
brenda
additional information
-
-
brenda
additional information
-
AAA activity shows a correlated expression with esterase activity at all stages, but the relative ratios of AAA to esterase activity are higher at younger stages, developmental expression patterns of AAA and AChE, overview
brenda
additional information
-
almost all organs
brenda
additional information
analysis of effects on the enzyme by fasting and high-glucose-fat diet treatments, association analysis of variations of GNPDA2 with productive traits in chicken tissues, overview. The complete transcript GNPDA2-a is predominantly expressed in adipose tissue (subcutaneous and abdominal fat), hypothalamus, and duodenum. In fasting chickens, the mRNA level of GNPDA2 is decreased by 58.8% in hypothalamus, and returned to normal level after refeeding. High-glucose-fat diet fed chicken show GNPDA2 gene expression about 2fold higher in adipose tissue compared to control (basal diet), but decreased expression in hypothalamus. Two single-nucleotide polymorphisms of the GNPDA2 gene are significantly associated with body weight and a number of fatness traits in chicken. Tissue specific expression of GNPDA2 variants in Xinghua chicken, no significantly different in expression level of all tissues between female and male chicken
brenda
additional information
analysis of effects on the enzyme by fasting and high-glucose-fat diet treatments, association analysis of variations of GNPDA2 with productive traits in chicken tissues, overview. The complete transcript GNPDA2-a is predominantly expressed in adipose tissue (subcutaneous and abdominal fat), hypothalamus, and duodenum. In fasting chickens, the mRNA level of GNPDA2 is decreased by 58.8% in hypothalamus, and returned to normal level after refeeding. High-glucose-fat diet fed chicken show GNPDA2 gene expression about 2fold higher in adipose tissue compared to control (basal diet), but decreased expression in hypothalamus. Two single-nucleotide polymorphisms of the GNPDA2 gene are significantly associated with body weight and a number of fatness traits in chicken. Tissue specific expression of GNPDA2 variants in Xinghua chicken, no significantly different in expression level of all tissues between female and male chickens
brenda
additional information
-
AS cell, inactive plus active p38 MAPK is predominantly expressed in cells of the fibrocartilaginous articular surface of joint elements
brenda
additional information
-
associated mainly with dividing tissues
brenda
additional information
-
broad expression of LIPI and LIPH, expression profiles, overview
brenda
additional information
-
Cdk5 is crucial for stability of axons and growth cones in retina
brenda
additional information
-
cell-free synthesis in mRNA-dependent rabbit reticulocyte lysate system
brenda
additional information
-
collagen type-specific isoenzymes
brenda
additional information
-
determination of dietary requirement for L-phenylalanine, indol acetic acid-phenylalanien or excess L-Phe cause slower growth rates, overview
brenda
additional information
-
digestive tract
brenda
additional information
-
enzyme expression and activity during ontogeny, detailed overview, no activity in ectoderm
brenda
additional information
-
enzyme expression is upregulated in hypertrophic chondrocytes compared to nonhypertrophic chondrocytes, 6fold higher mRNA level
brenda
additional information
-
enzyme is detected in all organs tested
brenda
additional information
-
enzyme is synthezised in the cytosol as the precursor protein and then imported into the mitochondria matrix and cleaved to the mature enzyme, the targeting information is encoded in nonoverlapping regions of the presequence
brenda
additional information
-
enzyme tissue distribution, no age-dependent differences, overview
brenda
additional information
expression pattern of 3X11A
brenda
additional information
immunohistochemic localization analysis, overview
brenda
additional information
immunoreactive protein is detected in all the tissues
brenda
additional information
-
influence of different feeding regimens on the specific activities of the enzyme in different tissues
brenda
additional information
isoform PAD2 protein is not detected in lung, heart, liver, granular stomach, and gizzard
brenda
additional information
lower mRNA level are found in liver, leg muscle, breast muscle, uropygial gland, heart, oviduct, testis, pituitary gland, cerebellum, small intestine, ovary, stomachus glandularis, cerebrum, hypothalamus, and proventriculus
brenda
additional information
-
method for histochemical localization of the enzyme
brenda
additional information
-
minimal activity also in lens, spleen, lung and pancreas
brenda
additional information
-
most abundant in tissues which display active polysaccharide synthesis
brenda
additional information
myosin light chain kinase is a ubiquitous Ca2+/calmodulin (CaM)-activated kinase found in smooth, cardiac, and skeletal muscle as well as in mammalian non-muscle cells
brenda
additional information
-
myosin light chain kinases in smooth muscle and non-muscle tissues are the same protein
brenda
additional information
-
no activity in liver and intestine with an exogenous receptor
brenda
additional information
-
no activity in liver, spleen, brain, oviduct, blood, and heart
brenda
additional information
-
no enzymatic activity in any tissue other than liver and kidney
brenda
additional information
no enzymic activity in liver
brenda
additional information
no expression in lung
brenda
additional information
no PCSK3 in head, ovary, and small intestine, expression in the adult, not embryo stage
brenda
additional information
-
not detected in brain
brenda
additional information
-
not in adult chicken or adult rabbit skeletal muscle
brenda
additional information
not in heart, liver, lung, abdominal fat, kidney, skeletal and heart muscle
brenda
additional information
-
not in leukocytes and ascites tumor cells
brenda
additional information
-
not: liver, kidney, heart, lung, adrenal gland, pancreas, salivary gland, skin
brenda
additional information
-
overview about distribution in animal tissues
brenda
additional information
-
overview tissue distribution of mitochondrial enzyme
brenda
additional information
-
overview: distribution in animal tissues
brenda
additional information
quantitative enzyme tissue expression analysis in the chicken oviduct during maturation
brenda
additional information
quantitative enzyme tissue expression analysis in the chicken oviduct during maturation. The MMP-7 mRNA expression is significantly higher on plastic than that on a gel substrate
brenda
additional information
-
SOD activity during storage at 4°C for 9 days in egg yolk and egg white, overview, no activity change during 6 days storage but between 6th and 9th day, it decreased significantly in egg yolk while remained low but unchanged in egg white
brenda
additional information
-
the concentration of CA-II in the erythrocytes of WL-chicken is much higher than that in erythrocytes from Araucana-chicken
brenda
additional information
the GATM gene displays biallelic expression in primordial germ cells as well as somatic embryonic, extraembryonic, and adult chicken tissues, tissue-specific expression analysis, overview. Very low expression in embryonic heart and fibroblasts
brenda
additional information
-
tissue distribution
brenda
additional information
-
two serine-rich heptapeptides, Ser-Ser-Ser-Lys-Ser-Ser-Ser (S6K) and Ser-Ser-Ser-Ser-Ser-Ser-Ser (S7) are fused to the C-terminus of chicken lysozyme by genetic modification. The cDNAs of S6K-lysozyme and S7-lysozyme are inserted into the expression vector of Pichia pastoris and secreted in the yeast cultivation medium. The secretion amounts of S6K-lysozyme and S7-lysozyme are about 60% of that of wild-type lysozyme
brenda
additional information
-
variety of cultured cells and cell lines
brenda
additional information
very low level in caecum, absent from lung
brenda
additional information
-
very low level of Art7.1 in DT40 cells
brenda
additional information
-
wide tissue distribution
brenda
additional information
-
widely distributed in varying tissues
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.